| For: | Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DTY. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 216-229 [PMID: 35110946 DOI: 10.3748/wjg.v28.i2.216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i2/216.htm |
| Number | Citing Articles |
| 1 |
Lei Wang, Jianjiang Pan, Bita Badehnoosh. Electrochemical biosensors for hepatocellular carcinoma. Clinica Chimica Acta 2025; 574 doi: 10.1016/j.cca.2025.120328
|
| 2 |
Mahrokh Abouali Gale Dari, Vahid Vahedian, Bartosz Kempisty, Olanrewaju B. Morenikeji, Maryam Farzaneh, Amir Anbiyaiee. The Protective Role of miR-125b in Hepatocellular Carcinoma: Unraveling Tumor-Suppressive Mechanisms. Current Molecular Medicine 2025; 25(6) doi: 10.2174/0115665240304247240529074123
|
| 3 |
Christine Bollwein, Nathan Heath Patterson, Alice Ly, Kristina Schwamborn, Naomi O'Sullivan, Juliana Pereira Lopes Gonçalves. Classification of small blue round cell tumors by integrating peptide and N-glycan mass imaging spectrometric profiles. Analytica Chimica Acta 2025; 1376 doi: 10.1016/j.aca.2025.344614
|
| 4 |
Long Shao, Biyu Zhang, Wei Wu, Gengyan Cui, Mao Liu. A Label-Free Photoelectrochemical Biosensor Based on ZnO/Cs3MnBr5 Heterogeneous Films for Alpha-Fetoprotein Detection. Nanomaterials 2024; 14(13) doi: 10.3390/nano14131127
|
| 5 |
Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. The American Surgeon™ 2024; 90(6) doi: 10.1177/00031348241227202
|
| 6 |
Sihao Lin, Kunpeng Fang, Li Geng. Bidirectional Mendelian randomization analysis reveals significant associations between Serum DNA repair proteins and liver cancer. Cancer Biomarkers 2026; 43 doi: 10.1177/18758592261429328
|
| 7 |
Gamalat A. Elgedawy, Naglaa S. Elabd, Asmaa M. Elbrolosy, Suzan M. El-Morshedy, Ayman El-Gamal, Mai Abozeid, Mervat Abdelkreem, Sama S. Eleowa, Marwa L. Helal. Circulating miR-485-5p as a potential diagnostic and prognostic biomarker for HCV-related hepatocellular carcinoma. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01625-y
|
| 8 |
Thaninee Prasoppokakorn, Areeya Buntho, Praewphan Ingrungruanglert, Thodsawit Tiyarattanachai, Tassanan Jaihan, Kittipat Kulkraisri, Darlene Ariyaskul, Chonlada Phathong, Nipan Israsena, Rungsun Rerknimitr, Sombat Treeprasertsuk, Roongruedee Chaiteerakij. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21888-9
|
| 9 |
Brian Sparkman, Kyeong Ri Yu, Apara Sai Jella, Leopoldo Fernandez, Jose Trevino, Adam Khader. Complex General Surgical Oncology. 2025; doi: 10.1007/978-3-031-88954-7_9
|
| 10 |
Ahmed Madni, Uswa Rana, Amna Rafiq, Hunza Hayat, Muhammad Zubair Iqbal, Waheed S. Khan, Sadia Z. Bajwa. MXene-based electrochemical sensors for cancer biomarker detection: current trends, challenges, and future directions. Microchimica Acta 2025; 192(12) doi: 10.1007/s00604-025-07638-4
|
| 11 |
Amani E. Marawan, Omar Ahmed Elmetwally, Mohamed M. Marwan, Mohamed M. A. El-Sokkary, Shimaa A. Abass, Laila A. Eissa. Diagnostic significance of gut Microbiome dysbiosis and biomarker expression in Egyptians with hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-28663-6
|
| 12 |
Min Kyung Park. Serum Biomarkers for Hepatocellular Carcinoma: A Comparative Review of Traditional and Emerging Markers. Journal of Digestive Cancer Research 2025; 13(3) doi: 10.52927/jdcr.2025.13.3.242
|
| 13 |
Edwin Wilbur Woodhouse, Tzu-Hao Lee, Susanna Naggie. Current Tools to Diagnose and Predict Hepatocellular Carcinoma: Relevance to HIV and Hepatitis B Virus Coinfection. Current HIV/AIDS Reports 2025; 22(1) doi: 10.1007/s11904-025-00757-w
|
| 14 |
Yaqin Zhan, Jinru Cao, Yan Li, Huihui Zeng, Yixing Li, Huaqiu Xu, Wenyi Huang, Hao Cheng, Si Gao, Yao Lu, Haibo Zhou, Jun Feng. SERS sensor based on metabolic oligosaccharide engineering for detection of glycosylated CEs1 in HepG-2 cells. Sensors and Actuators B: Chemical 2026; 465 doi: 10.1016/j.snb.2026.140239
|
| 15 |
Hong Lin, Yu Tu, Pinghan Wang, Ting Wang, Fangyi Long. The bench-to-bedside journey of circular RNAs in cancer: Status, challenges and future prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2026; 1881(4) doi: 10.1016/j.bbcan.2026.189639
|
| 16 |
Zbigniew Wyżewski, Karolina Paulina Gregorczyk-Zboroch, Matylda Barbara Mielcarska, Weronika Świtlik, Adrianna Niedzielska. Bid Protein: A Participant in the Apoptotic Network with Roles in Viral Infections. International Journal of Molecular Sciences 2025; 26(6) doi: 10.3390/ijms26062385
|
| 17 |
Nava Moghadasian Niaki, Faezeh Hatefnia, Mohammad Mahdi Heidari, Mahsa Tabean, Ahmad Mobed. Alpha-Fetoprotein (AFP) biosensors. Clinica Chimica Acta 2025; 573 doi: 10.1016/j.cca.2025.120293
|
| 18 |
Qingmei Deng, Xinhui Zhang, Xiaofeng Wan, Xin Zheng, Hongzhi Wang, Jingyu Zhao, Hong-Qiang Wang, Wulin Yang. The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma. Heliyon 2024; 10(5) doi: 10.1016/j.heliyon.2024.e26774
|
| 19 |
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
|
| 20 |
Yee Hui Yeo, Yi-Te Lee, Hsian-Rong Tseng, Yazhen Zhu, Sungyong You, Vatche G. Agopian, Ju Dong Yang. Alpha-fetoprotein: Past, present, and future. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000422
|
| 21 |
Hayet Aouragh, Hayat Ait Kaci, Imene Haroun, Safia Zenia, Lynda Abdellaoui, Nadjet Amina Khelifi Touhami, Nassim Ouchene, Dalila Tarzaali, Kamel Bentabak, Leila Saadi. Gender-Related Differences in Clinical and Pathological Characteristics of Algerian Pa-tients with Hepatocellular Carcinoma: A 22 Year Retrospective Study. Iranian South Medical Journal 2025; 28(2) doi: 10.66224/ismj.28.2.611
|
| 22 |
Man-Fung Yuen, David Wastlund, Tammie Tan Yan Lin, Qishi Zheng, Junqiao Chen, Kwan-Lung Ko, Jee-Fu Huang. Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong. PLOS One 2026; 21(7) doi: 10.1371/journal.pone.0353882
|
| 23 |
Tatjana Ivaskiene, Greta Kaspute, Arunas Ramanavicius, Urte Prentice. Molecularly Imprinted Polymer Advanced Hydrogels as Tools for Gastrointestinal Diagnostics. Gels 2025; 11(4) doi: 10.3390/gels11040269
|
| 24 |
Dahrii Paul, Vigneshwar Suriya Prakash Sinnarasan, Rajesh Das, Md Mujibur Rahman Sheikh, Santhosh Manickannan, Amouda Venkatesan. UriPred: Machine learning prediction of urinary proteins and identification of biomarkers for liver cancer. Computational Biology and Chemistry 2026; 122 doi: 10.1016/j.compbiolchem.2026.108946
|
| 25 |
Tian Yang, Nanya Wang, Fengmei Wang, Hongmei Liu, Feng Shen, Guoyue Lv. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol. BMJ Open 2023; 13(9) doi: 10.1136/bmjopen-2023-076467
|
| 26 |
Pooja Basthi Mohan, Rajiv Lochan, Shiran Shetty. Biomarker in Hepatocellular Carcinoma. Indian Journal of Surgical Oncology 2024; 15(S2) doi: 10.1007/s13193-023-01858-x
|
| 27 |
Heba Amer, A. Elfakhry, El-Hafez Abd, Arman El, Fatma Abozeid. Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis. Scripta Medica 2026; 57(3) doi: 10.5937/scriptamed57-65514
|
| 28 |
Adil Farooq Wali, Abid Reza Ansari, Prince Ahad Mir, Mohamed El-Tanani, Rasha Babiker, Md Sadique Hussain, Jasreen Uppal, Asma Ishrat Zargar, Reyaz Hassan Mir. Epigenetic Alterations in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Therapeutic Implications. Pharmaceuticals 2025; 18(9) doi: 10.3390/ph18091281
|
| 29 |
Amy B. Kolbe, Michael R. Acord, Geetika Khanna, Cara E. Morin, HaiThuy N. Nguyen, Mitchell A. Rees, Esther Ro, Gary R. Schooler, Judy H. Squires, Ali B. Syed, Elizabeth R. Tang, Alexander J. Towbin, Adina Alazraki. Imaging Findings and Management Strategies for Liver Masses in Children with Predisposition Disorders: A Review by the Pediatric LI-RADS Group. RadioGraphics 2025; 45(1) doi: 10.1148/rg.240063
|
| 30 |
Xian‐Yang Qin, Yohei Shirakami, Masao Honda, Shiou‐Hwei Yeh, Kazushi Numata, Ya‐Yun Lai, Chiao‐Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei‐Jer Chen, Hisataka Moriwaki, Harukazu Suzuki. Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International Journal of Cancer 2024; 155(3) doi: 10.1002/ijc.34893
|
| 31 |
Weihao Tang, Xiaoke Ma. Identification of Causal Plasma Proteins in Hepatocellular Carcinoma via Two-Sample Mendelian Randomization and Integrative Transcriptomic‒Proteomic Analysis. Cancer Research Communications 2025; 5(3) doi: 10.1158/2767-9764.CRC-24-0553
|
| 32 |
Chao Lv, Nan He, Jie Jie Yang, Jing Jing Xiao, Yan Zhang, Jun Du, Shi Zuo, Hai Yang Li, Huajian Gu. Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study. The British Journal of Radiology 2023; 96(1145) doi: 10.1259/bjr.20220702
|
| 33 |
Ani Gvajaia, Michael Imeh, Ali Raza. An Interesting Case of Alpha-Fetoprotein (AFP)-Producing Pancreaticoduodenal Tumor. Cureus 2024; doi: 10.7759/cureus.59384
|
| 34 |
Faisal Alshomrani. Recent Advances in Magnetic Resonance Imaging for the Diagnosis of Liver Cancer: A Comprehensive Review. Diagnostics 2025; 15(16) doi: 10.3390/diagnostics15162016
|
| 35 |
Amina A Abd El Fattah, Magdy M Youssef, Mohamed Abdel-Wahab, Mona S Gouida, Hoda M El-Emshaty. Assessment of osteopontin and vascular endothelial growth factor for diagnostic performance of Egyptians hepatocellular carcinoma. Laboratory Medicine 2026; 57(1) doi: 10.1093/labmed/lmaf075
|
| 36 |
Saeed Ahmad, Sadia Paracha, Rahmat Ali, Syed Muhammad Ali Akbar, Muhammad Ahsan Asif, Muhammad Osama Saeed, Roma Bai, Hafiz Muhammad Tousif Afzal, Syed Bilal Shah, Daryl T.Y. Lau. Nonadherence to Antiviral Therapy Leading to Severe Hepatic Decompensation in a Patient With Chronic Hepatitis B. ACG Case Reports Journal 2026; 13(2) doi: 10.14309/crj.0000000000001999
|
| 37 |
Tianhui Zhou, Yingying Zhang, Yuqing Lu, Zhaodong Sun, Dehui Wang, Xiaolong Zhang, Yu Wang, Yinuo Wei, Tiange Zhang, Xin Zhang, Ruohan Wei, Po Hu, Guangming Yang, Xinzhu Wang, Yang Pan. The Efficacy of Combined Use of Huaier Granules in the Treatment of Primary Liver Cancer: An Updated Systematic Review and Meta-Analysis. Pharmaceuticals 2025; 18(6) doi: 10.3390/ph18060884
|
| 38 |
Shuting Huang, Wanqiu Li, Kaifang Wang, Yu Cai, Lirui Qian, Yiran Liu, Feng Gao, Tong Fang, Kin Yip Tam, Ou Sha. Integrative pan-cancer analysis identifies CCHCR1 as a prognostic biomarker and therapeutic target driving EMT in hepatocellular carcinoma via PI3K/AKT activation. Genes & Diseases 2026; 13(5) doi: 10.1016/j.gendis.2025.101960
|
| 39 |
Jun Liu, Kevin Park, Ziyang Shen, Hannah Lee, Purnima Geetha, Mohammadreza Pakyari, Li Chai. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1285370
|
| 40 |
Shafaq Saleem, Muhammad Salman Sajid, Rency S. Varghese, Zaki A. Sherif, Alexander Kroemer, Habtom W. Ressom. Phosphopeptidome Profiling of Human Plasma for Hepatocellular Carcinoma Biomarker Discovery. Journal of Proteome Research 2026; 25(2) doi: 10.1021/acs.jproteome.5c01004
|
| 41 |
Junying Ge, Jianzhi Dou, Xifeng Yu, Yue Sun, Haiyan Song, Dazhong Shen. Simultaneous determination of α-fetoprotein and carbohydrate antigens 125 and 19–9 in potential- and spectrum-resolved dual-mode electrochemiluminescence. Microchemical Journal 2024; 199 doi: 10.1016/j.microc.2024.110117
|
| 42 |
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13) doi: 10.1007/s00432-023-05057-7
|
| 43 |
Joshua J. Lingo, Maggie M. Balas, Philipp E. Scherer, Jason C. Klein. The Role of COL6A3 in Tumorigenesis, Metastasis, Diagnosis, and Disease Management. Cancers 2025; 17(21) doi: 10.3390/cancers17213449
|
| 44 |
Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan. Advances in human reproductive biomarkers. Clinica Chimica Acta 2024; 552 doi: 10.1016/j.cca.2023.117668
|
| 45 |
Noor Kadhim Yousif, Safa Asaad Ahmed. Novel Biomarkers in Histopathology: Implications for Diagnosis and Prognosis. European Journal of Medical and Health Research 2024; 2(6) doi: 10.59324/ejmhr.2024.2(6).06
|
| 46 |
Xing Lv, Peng-Bo Zhang, Er-lei Zhang, S. Yang. Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03765-7
|
| 47 |
Wushuang Gong, Jiaqi Wu, Hong Wei, Zhaopeng Jiang, Ming Wan, Chengwei Wu, Weili Xue, Rao Ma, Xianli Zhou, Hang Zhou. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients. La radiologia medica 2023; 128(4) doi: 10.1007/s11547-023-01614-9
|
| 48 |
Hui-Hui Hu, Xuefeng Wang, Bin Lan, Haili Cheng, Hong Wen, Fangfang Chen, Jianfeng Wu, Mengqi Li, Jiazhou Chen, Jinhui Zhang, Dongxu Chen, Shiyu Lin, Jieyu Lin, Mingyang Yang, Zhenhua Wu, Zhong-Zheng Zheng, Fuqing Chen, Jianyin Zhou, Gang Chen, Yu Chen, Xianming Deng, Chen-Song Zhang, Jingfeng Liu, Sheng-Cai Lin. Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages. Cell Research 2025; 35(12) doi: 10.1038/s41422-025-01195-4
|
| 49 |
Bangjie Li, Jialiang Hu, Hanmei Xu. Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1455383
|
| 50 |
Rita Andrade, Judith Perez-Rojas, Sílvia Gomes da Silva, Migla Miskinyte, Margarida C. Quaresma, Laura P. Frazão, Carolina Peixoto, Almudena Cubells, Eva M. Montalvá, António Figueiredo, Augusta Cipriano, Maria Gonçalves-Reis, Daniela Proença, André Folgado, José B. Pereira-Leal, Rui Caetano Oliveira, Hugo Pinto-Marques, José Guilherme Tralhão, Marina Berenguer, Joana Cardoso. HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity. Cancers 2025; 17(3) doi: 10.3390/cancers17030500
|
| 51 |
Rebeca Sierra, Ana Marenco-Flores, Marwan Alsaqa, Romelia Barba, Marcela Cuellar-Lobo, Carla Barberan, Leandro Sierra. Autoimmune Hepatitis Management: Recent Advances and Future Prospects. Livers 2024; 4(2) doi: 10.3390/livers4020017
|
| 52 |
Sikander S. Gill, Rajwant K. Gill, R. C. Sobti. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; doi: 10.1007/978-981-99-2196-6_7-1
|
| 53 |
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Therapy 2024; 31(8) doi: 10.1038/s41417-024-00764-w
|
| 54 |
Gabrielle Griffin, Morgan E. Delnicki, Haiyan Lu, Idoia Meaza, Aggie Williams, Samuel T. Vielee, Oluwanifemi Esther Bolatimi, Rachel M. Wise, Rui Liu, J. Calvin Kouokam, Sandra S. Wise, John Pierce Wise, Matthew C. Cave, John P. Wise, Jamie Lynn Wise. Exposure to low levels of hexavalent chromium in drinking water alters diet-induced steatotic liver disease in male rats. Journal of Trace Elements in Medicine and Biology 2025; 91 doi: 10.1016/j.jtemb.2025.127731
|
| 55 |
Hyo Jung Park, So Yeon Kim, Young‐Suk Lim. Updates in Abbreviated MRI‐Based HCC Surveillance. Journal of Gastroenterology and Hepatology 2026; 41(3) doi: 10.1111/jgh.70285
|
| 56 |
Gregory D. Kirk, Sara Nsibirwa, Jim K. Aizire, Redeat L. Assefa, Antonio Bandala-Jacques, Jackson Orem, Tongai Maponga, Moussa Seydi, Gilles Wandeler, Amir Mohareb, David L. Thomas, Fred Okuku, Emmanuelle Ochola, Ponsiano Ocama. Pragmatic Approach to Hepatocellular Carcinoma Diagnosis in High-Incidence, Resource-Limited Settings in Africa. JCO Global Oncology 2025; (11) doi: 10.1200/GO-24-00592
|
| 57 |
Haukur Einarsson, Rondell P. Graham. How Do I Diagnose Fibrolamellar Carcinoma?. Modern Pathology 2025; 38(4) doi: 10.1016/j.modpat.2025.100711
|
| 58 |
Roberta Barbizan Mascarello, Jéssica Lamberty Faverzani, Franciele Fátima Lopes, Luísa Maria Bosquetti Tedesco, Ana Kalise Böttcher, Moacir Wajner, Carmen Regla Vargas. Nitisinone treatment protect hereditary tyrosinemia type I patients against inflammation, DNA and protein oxidative damage by decreasing succinylacetone levels. Metabolic Brain Disease 2025; 40(7) doi: 10.1007/s11011-025-01719-2
|
| 59 |
Xinjun Sun, Fengyan Fang, Jintong Na, Runjie Yan, Yong Huang, Zhide Zhou, Yongxiang Zhao, Guiyin Li. Fluorescent "turn-on" aptamer sensor for sensitive and reliable detection of Golgi glycoprotein 73 based on nitrogen-doped graphene quantum dots and molybdenum disulfide nanosheets. Journal of Pharmaceutical and Biomedical Analysis 2023; 225 doi: 10.1016/j.jpba.2022.115215
|
| 60 |
Pratibha Pandey, Deena Elsori, Rahul Kumar, Sorabh Lakhanpal, Indra Rautela, Tariq Mohammed Alqahtani, Fuzail Ahmad, Danish Iqbal, Fahad Khan. Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1399677
|
| 61 |
Dizhong Ye, Biyan Chen, Xiangfa Wang, Weiwei Chen, Feng Ye, Guangqian Quan. LncRNA CTB-31O20.2 promotes the progression of hepatocellular carcinoma by targeting the miR-139-5p/ROCK1 axis. Archives of Biochemistry and Biophysics 2025; 774 doi: 10.1016/j.abb.2025.110619
|
| 62 |
Yongling Chen, Ziqing Zhong, Xuelian Ruan, Xiuyu Zhan, Yanting Ding, Fangyi Wei, Xue Qin, Hongli Yu, Yu Lu. Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1. Digestive and Liver Disease 2025; 57(3) doi: 10.1016/j.dld.2024.11.008
|
| 63 |
Leonie Hose, Alina Celine Tekin, Bart Verwaaijen, Rayoung Kim, Christian Rückert-Reed, Ulrich Hamberger, Tobias Busche, Lars-Uwe Scholtz, Frank Brasch, Ingo Todt, Peter Goon, Matthias Schürmann. Diagnostic accuracy of combinatorial mRNA biomarkers for non-invasive detection and therapy monitoring of oral and oropharyngeal SCC. British Journal of Cancer 2026; 134(6) doi: 10.1038/s41416-025-03313-w
|
| 64 |
Dong Hwan Kim, Sang Hyun Choi, Boyeon Koo, Se Jin Choi, Hyeon Ji Jang, Subin Heo, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin. Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma. European Radiology 2025; 35(8) doi: 10.1007/s00330-025-11418-2
|
| 65 |
Sun Jae Park, Yun Young Lee, Yong-Kyu Chung, Bo-Hyun Jung, Joon An, Jinil Han, Youngho Moon, Hee-Jung Wang.
Development and validation of a digital PCR assay targeting plasma
FAR1
methylation for early detection of hepatocellular carcinoma
. Epigenetics 2026; 21(1) doi: 10.1080/15592294.2026.2653956
|
| 66 |
Qu Xie, Zeyin Zhao, Yanzhen Yang, Dan Long, Cong Luo. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection. Journal of Cancer Research and Clinical Oncology 2023; 149(16) doi: 10.1007/s00432-023-05291-z
|
| 67 |
Mahati Munikoti Srikantamurthy, Parneet Kaur, Eckart Bindewald, Maytha Naif Alshammari, Srinivas Thirunagari, Nachiappan Dhatchana Moorthy. Cross-study transcriptomics and machine learning approaches reveal a predictive six-gene panel for hepatocellular carcinoma. Medicine in Omics 2026; doi: 10.1016/j.meomic.2026.100061
|
| 68 |
Audrey Kapelanski-Lamoureux, Anthoula Lazaris, Nicholas Meti, Peter Metrakos. Current Immunotherapy Strategies and Emerging Biomarkers for the Treatment of Hepatocellular Carcinoma. Cancers 2025; 17(23) doi: 10.3390/cancers17233870
|
| 69 |
Suhad Mohammed Mahmoud, Athraa Zaidan Hassan, Salah M. Hassan, Safaa A. A. Alwaysi. Assessment of serum AFP, GP73, GPC-3 for diagnosis of cirrhosis and hepatocellular carcinoma in Iraqi patients with chronic hepatitis B. THIRD INTERNATIONAL SCIENTIFIC CONFERENCE: SISC2024 2026; 3415 doi: 10.1063/5.0322701
|
| 70 |
Wentao Zhu, Pei Shi, An Liang, Ying Zhu, Jiwei Fu, Songsong Yuan, Xiaoping Wu. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10139-9
|
| 71 |
Guoxu Fang, Jianhui Fan, Zongren Ding, Yongyi Zeng. Application of biological big data and radiomics in hepatocellular carcinoma. iLIVER 2023; 2(1) doi: 10.1016/j.iliver.2023.01.003
|
| 72 |
Reem El-Shenawy, Rehab I. Moustafa, Naiera M. Helmy, Yasmine S. El-Abd, Ashraf A. Tabll, Yasser K. Elesnawy, Heba Shawky. Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02551-3
|
| 73 |
Vlad Bogdan Varzaru, Anca-Elena Eftenoiu, Daliborca Cristina Vlad, Cristian Sebastian Vlad, Aurica Elisabeta Moatar, Roxana Popescu, Ionut Marcel Cobec. The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters. Life 2024; 14(4) doi: 10.3390/life14040458
|
| 74 |
Faezeh Ghorbanizamani, Hichem Moulahoum, Suna Timur. Ionic liquid-reinforced Hydroxyapatite@nano-TiO2 as a green platform for Immuno-electrochemical sensing applications. Talanta 2024; 280 doi: 10.1016/j.talanta.2024.126688
|
| 75 |
Jing Xu, Lin Tan, Ning Jiang, Feng Zhang, Jinling Wang, Fengcheng Li, Jin Wang, Heng Li, Lichang Chen, Olivia Mezzetti, Wenyu Lin, Shasha Li, Yufeng Gao. Integrating GPC3 with Other Biomarkers to Improve the Diagnosis of Early-Stage Liver Cancer. Pathogens 2025; 14(12) doi: 10.3390/pathogens14121189
|
| 76 |
Adonis A Protopapas, Alexandra Tsankof, Ioanna Papagiouvanni, Georgia Kaiafa, Lemonia Skoura, Christos Savopoulos, Ioannis Goulis. Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide. World Journal of Hepatology 2024; 16(12): 1377-1394 doi: 10.4254/wjh.v16.i12.1377
|
| 77 |
Xinyi Yang, Zhuokun Du, Yuxin Jiao, Sijie Chen, Juanjuan Ning, Haotian Hong, Bin Fu, Jiayu Liu, Wanjun Zhang, Weijie Qin. An Integrated Strategy Using Predicted Spectral Library and Tandem Enrichment for Large-Scale Identification of Low-Abundance Proteins and Intact N-Glycopeptides in Human Plasma. Analytical Chemistry 2025; 97(29) doi: 10.1021/acs.analchem.5c02002
|
| 78 |
Cristina-Paula Ursu, Luminița Elena Furcea, Bogdan Procopeț, Răzvan Alexandru Ciocan, Ștefan Ursu, Claudia Diana Gherman, Dan Vălean, Rodica Sorina Pop, Emil Ioan Moiș, Horia Ștefănescu, Carmen Socaciu, Nadim Al Hajjar, Florin Graur. Differential Metabolic Dysregulations in Hepatocellular Carcinoma and Cirrhosis: Insights into Lipidomic Signatures. Biomolecules 2025; 15(11) doi: 10.3390/biom15111575
|
| 79 |
Hanna Hong, Chase J. Wehrle, Mingyi Zhang, Sami Fares, Henry Stitzel, David Garib, Bassam Estfan, Suneel Kamath, Smitha Krishnamurthi, Wen Wee Ma, Teodora Kuzmanovic, Elizabeth Azzato, Emrullah Yilmaz, Jamak Modaresi Esfeh, Maureen Whitsett Linganna, Mazhar Khalil, Alejandro Pita, Andrea Schlegel, Jaekeun Kim, R. Matthew Walsh, Charles Miller, Koji Hashimoto, David Choon Hyuck Kwon, Federico Aucejo. Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept. Cancers 2024; 16(5) doi: 10.3390/cancers16050927
|
| 80 |
Cheng Zheng, Mengyuan Cui, Yingyu Zhang, Li Liu, Wenqing Li, Jiaqi Zhang, Min Ji, Wei Chen, Wen Jiang, Peng Wang, Wancun Zhang. Universal sulfatase-based chemiluminescence biosensing platform: Validation via AFP detection in clinical blood samples. Biosensors and Bioelectronics 2025; 267 doi: 10.1016/j.bios.2024.116771
|
| 81 |
Samiksha Antil, Saravjeet Singh.
Novel La
2
O
3
/g-C
3
N
4
Nanocomposite Electrochemical Immunosensor for Sensitive Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma
. Analytical Letters 2026; 59(15) doi: 10.1080/00032719.2026.2625401
|
| 82 |
Joaquin Blanco, Luis D. Gonzalez, Abigail Cortes, Nidia Jimenez, Mario R. Pavia, María X. Gutierrez. Obstructive jaundice as the initial manifestation of hepatocellular carcinoma in a patient with previously unknown chronic hepatitis B infection: a case report and literature review. International Journal of Research in Medical Sciences 2024; 13(1) doi: 10.18203/2320-6012.ijrms20244137
|
| 83 |
Viola Ceconi, Valentina Kiren, Flora Maria Murru, Andrea Bon, Danica Dragovic, Lorenzo Zandonà, Alice Fachin, Gianluca Tamaro, Gianluca Tornese. Elevated Alpha-Fetoprotein in Hypothyroidism. LabMed 2025; 2(4) doi: 10.3390/labmed2040024
|
| 84 |
Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang. Value of des-gamma-carboxy prothrombin in comprehensive management of hepatocellular carcinoma. World Chinese Journal of Digestology 2026; 34(2) doi: 10.11569/wcjd.v34.i2.110
Abstract(108) |
Core Tip(111) |
Full Article(HTML)(514)
|
Times Cited (0)
|
Total Visits (657)
|
Open
|
| 85 |
Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K. Singla, Rohit Sharma. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug Metabolism and Personalized Therapy 2024; 39(1) doi: 10.1515/dmpt-2023-0056
|
| 86 |
Dattatrya Shetti, Venkata Ramana Mallela, Wenjing Ye, Mahyar Sharif, Filip Ambrozkiewicz, Andriy Trailin, Václav Liška, Kari Hemminki. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2024; 200 doi: 10.1016/j.critrevonc.2024.104391
|
| 87 |
Meijie Yu, Hang Zhou, Xinyan Ma, Huilin Xia, Hong Zhang, Yuan Lu, Hongbo Chen, Rongbin Yu, Yifan Wang, Peng Huang. Repeated measurements of alpha fetoprotein and fibrosis-4 predict long term hepatocellular carcinoma and mortality risks after antiviral therapy. Infectious Medicine 2026; 5(2) doi: 10.1016/j.imj.2026.100252
|
| 88 |
Fabrício Freire de Melo, Manuel Alvarez Troncoso Corbacho, Naide Oliveira Sousa, Jayne Ferreira Da Silva, Gabriel De Melo Olegário, André Alves Dos Santos, Nathalia de Andrade Simon, Rafick Costa Dos Santos Da Silva. Personalized medicine: Clinical oncology on molecular view of treatment. World Journal of Clinical Oncology 2024; 15(8): 992-1001 doi: 10.5306/wjco.v15.i8.992
|
| 89 |
Huinan Chen, Jingyao Song, Yuanyuan Li, Dongmei Deng, Yuchen Song, Xiaoli Zhu, Liqiang Luo. Cascade signal amplifying strategy for ultrasensitive detection of tumor biomarker by DNAzyme cleaving mediated HCR. Sensors and Actuators B: Chemical 2024; 420 doi: 10.1016/j.snb.2024.136466
|
| 90 |
Ludovico Abenavoli, Giuseppe G.M. Scarlata, Maria L. Gambardella, Ivo Lopez, Giuseppe Sena, Domenico Laganà, Francesco Luzza, Giuseppe Currò. Gender, Age, Alpha-fetoprotein, and Des-gamma-carboxyprothrombin Score as a Novel Approach to Early Detection of Hepatocellular Carcinoma: A Narrative Review. Journal of Clinical and Experimental Hepatology 2026; 16(1) doi: 10.1016/j.jceh.2025.103203
|
| 91 |
Sara Rezapour, Farin Khodam Mohammadi, Mahmoud Darweesh, Saeed Mohammadi, Saeid Afshar, Sevgi Marakli. MicroRNA Binding Site Polymorphisms in Hepatocellular Carcinoma: Implications for Pathogenesis, Prognosis, and Therapeutic Response. International Journal of Genomics 2025; 2025(1) doi: 10.1155/ijog/9520856
|
| 92 |
Han Li, Chengyuan Zhou, Chenjie Wang, Bo Li, Yanqiong Song, Bo Yang, Yan Zhang, Xueting Li, Mingyue Rao, Jianwen Zhang, Ke Su, Kun He, Yunwei Han. Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma. Clinical and Translational Oncology 2024; 27(1) doi: 10.1007/s12094-024-03588-0
|
| 93 |
Masato Kojima, Kensuke Hattori, Hajime Uchida, Ryuji Komine, Yusuke Yanagi, Akinari Fukuda, Chizuko Haga, Takako Yoshioka, Seisuke Sakamoto, Mureo Kasahara. Incidental Hepatoblastoma in an Infant Who Underwent Liver Transplantation for Cryptogenic Liver Cirrhosis: A Case Report. Pediatric Transplantation 2026; 30(6) doi: 10.1111/petr.70369
|
| 94 |
Bing Cong, Pengli Li, Hongling Li, Chenglin Hong, Xiuwen Qiao. A pH-responsive hollow mesoporous SiO2 nanocarrier designed for the ultrasensitive detection of alpha-fetoprotein. New Journal of Chemistry 2023; 47(47) doi: 10.1039/D3NJ03758D
|
| 95 |
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric Miller, Ashish Manne. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?. International Journal of Molecular Sciences 2023; 24(18) doi: 10.3390/ijms241814231
|
| 96 |
Jie You, Yihuan Huang, Chenhao Jiang, Jiaqi Xiao, Jiebin Zhang, Yasong Liu, Xin Sui, Yingcai Zhang, Jia Yao, Tongyu Lu. EMP1 + hepatic stellate cells drive hepatic fibrosis progression to hepatocellular carcinoma and predict prognosis. Journal of Translational Medicine 2025; 24(1) doi: 10.1186/s12967-025-07454-7
|
| 97 |
Tianyi Lv, Xingen Gao, Juqiang Lin, Xianqiong Gong, Fuqiang Wang, Junzheng Wu, Hongyi Zhang, Nianyin Zeng. Prior knowledge-guided adaptive multi-scale deep learning for Surface-Enhanced Raman Spectroscopy-based liver disease classification. Engineering Applications of Artificial Intelligence 2026; 167 doi: 10.1016/j.engappai.2026.113941
|
| 98 |
Amparo Roa-Colomo, María Ángeles López Garrido, Pilar Molina-Vallejo, Angela Rojas, Mercedes González Sanchez, Violeta Aranda-García, Javier Salmeron, Manuel Romero-Gomez, Jordi Muntane, Javier Padillo, Jose María Alamo, Jose A. Lorente, María José Serrano, M. Carmen Garrido-Navas. Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1074277
|
| 99 |
Jie Zhao, Shuangzhen Gu, Zhen Wu, Xiaoliang Han. Integrating a methylation‐based liquid biopsy into early liver cancer diagnostic pathways: Clinical insights from a trial. Clinical and Translational Discovery 2026; 6(3) doi: 10.1002/ctd2.70167
|
| 100 |
Hyunjung Kim, Minji Jang, Eunmi Kim. Exploring the Multifunctional Role of Alpha-Fetoprotein in Cancer Progression: Implications for Targeted Therapy in Hepatocellular Carcinoma and Beyond. International Journal of Molecular Sciences 2025; 26(10) doi: 10.3390/ijms26104863
|
| 101 |
Motahareh Sadat Raziyan, Arvydas Palevicius, Giedrius Janusas. Review—Electrochemical Biosensors for Alpha-Fetoprotein Detection: Recent Advances and Future Perspectives. Journal of The Electrochemical Society 2024; 171(7) doi: 10.1149/1945-7111/ad586f
|
| 102 |
Changjiang Liu, Feng Gao, Jie Yang, Chengang Liu, Ziqiang Tian. Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5. American Journal of Clinical Oncology 2024; 47(10) doi: 10.1097/COC.0000000000001116
|
| 103 |
Xiao-Jun Yang, Xing-Xue Niu. Letter to the Editor: Serum alpha-fetoprotein dynamics in liver failure - prognostic implications and clinical insights. World Journal of Hepatology 2026; 18(4): 114861 doi: 10.4254/wjh.v18.i4.114861
|
| 104 |
Martyna E. Berej, Joanna J. Kośka, Maria Marta Orzeł, Beata Borek-Dzięcioł. Highly Elevated Alpha-fetoprotein Concentration in a Premature Infant. Journal of Clinical Neonatology 2024; 13(3) doi: 10.4103/jcn.jcn_16_24
|
| 105 |
Weiguo Liu, Moli Chen, Xue Wei, Peng Wang. Hepatocellular carcinoma with renal invasion and its multimodal management: a rare case report. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1764947
|
| 106 |
Mohd Basheeruddin, Sana Qausain, Ashish Anjankar, Faez Iqbal Khan. Advancements in cancer biomarker discovery over fifteen years: diagnostics and prognostic approach in somatic cancer. Oncology Reviews 2026; 20 doi: 10.3389/or.2026.1809836
|
| 107 |
Tesfaye Wolde, Vipul Bhardwaj, Vijay Pandey. Current Bioinformatics Tools in Precision Oncology. MedComm 2025; 6(7) doi: 10.1002/mco2.70243
|
| 108 |
Nunzio Marroncelli, Giulia Ambrosini, Andrea Errico, Sara Vinco, Elisa Dalla Pozza, Giulia Cogo, Ilaria Cristanini, Filippo Migliorini, Nicola Zampieri, Ilaria Dando. Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis. Cancers 2025; 17(14) doi: 10.3390/cancers17142409
|
| 109 |
Jinxin Sheng, Ri Wang, Haifan Yang, Zhong Zhao, Shichen Qin, Jie Yao, Guang Yang, Xiaowei Cao, Xinghai Yang, Xiaoyong Wang. Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins. Photodiagnosis and Photodynamic Therapy 2024; 49 doi: 10.1016/j.pdpdt.2024.104336
|
| 110 |
Zhuo Li, Na Zhang, Zewen Dong, Xin Wang, Jian Zhou, Juan Gao, Yunyun Yang, Jing Li, Feng Guan, Yue Zhou, Zengqi Tan. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01569-y
|
| 111 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1) doi: 10.3233/TUB-220023
|
| 112 |
Ke Wei, Chunxiu Peng, Yangzhi Ou, Pengchen Wang, Chenjie Zhan, Huaxiu Wei, Jintong Na, Zhiyong Zhang. Decoding Hepatocellular Carcinoma Metastasis: Molecular Mechanisms, Targeted Therapies, and Potential Biomarkers. Current Issues in Molecular Biology 2025; 47(4) doi: 10.3390/cimb47040263
|
| 113 |
Peng Fu, Binbin Gong, Huiming Li, Qing Luo, Zikun Huang, Renfeng Shan, Junming Li, Shaoying Yan. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus‐related hepatocellular carcinoma. International Journal of Cancer 2022; 151(10) doi: 10.1002/ijc.34201
|
| 114 |
Ting Huang, Yong Chen. Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06349-3
|
| 115 |
Lingyun Li, Aoshan Wang, Xiongqing Liu, Ganlu Wang, Shanjie Xu, Changjiang Li, Wenzhong Wu, Xiaoying Zhang, Zhendan He, Huiling Qiu, Xiao Peng, Wei Yan, Junle Qu. Fluorescence lifetime imaging microscopy approach reveals quantitative signatures for hepatocellular carcinoma diagnosis. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1598334
|
| 116 |
Xinmiao Liu, Yefan Zhang, Narisu Narisu, Fan Wu, Ke Zhang, Yulin Sun, Hongjun Gao. A robust ddPCR assay for the absolute quantification of miR-192-5p in hepatocellular carcinoma liquid biopsies. Clinical Chemistry and Laboratory Medicine (CCLM) 2026; 64(3) doi: 10.1515/cclm-2025-0824
|
| 117 |
Brett T. Spear, Martha L. Peterson. Reference Module in Life Sciences. 2024; doi: 10.1016/B978-0-12-822563-9.00211-0
|
| 118 |
Yuxiang Lin, Qiyi Zhang, Hanxi Chen, Shuhang Liu, Kaiming Peng, Xiaojie Wang, Liyong Zhang, Jun Huang, Xiuqing Yan, Xueliang Lin, Uddin M. D. Hasan, Mahabub Sarwara, Fangmeng Fu, Shangyuan Feng, Chuan Wang. Multi-cancer early detection based on serum surface-enhanced Raman spectroscopy with deep learning: a large-scale case–control study. BMC Medicine 2025; 23(1) doi: 10.1186/s12916-025-03887-5
|
| 119 |
Yehor Lazar, Danylo Yevdoshenko, Anastasiya Mazur, Olena Mіronova , Нanna Romanenko, Anatoly Makarenko. The use of complex radionuclide methods in the detection of metastatic lesions of the skeleton and liver in kidney cancer. The Ukrainian Scientific Medical Youth Journal 2025; 157(3) doi: 10.32345/USMYJ.3(157).2025.89-102
|
| 120 |
Yiwen Lin, Yijie Chen, Chunhui Deng, Nianrong Sun. Integration of resol/block-copolymer carbonization and machine learning: A convenient approach for precise monitoring of glycan-associated disorders. Chinese Chemical Letters 2024; 35(12) doi: 10.1016/j.cclet.2024.109813
|
| 121 |
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565 doi: 10.1016/j.cca.2024.119977
|
| 122 |
Jan Musiałkiewicz, Marek Ruchała, Paweł Komarnicki, Adam Maciejewski, Joanna Sienkiewicz, Phantira Sirisachadecha, Bartłomiej Budny, Paweł Gut. Longitudinal analysis of serum alpha-fetoprotein in stable and progressive metastatic pancreatic neuroendocrine tumours. Endocrine Connections 2025; 14(9) doi: 10.1530/EC-25-0350
|
| 123 |
Azeez Okikiola Lawal, Tolutope Joseph Ogunniyi, Oriire Idunnuoluwa Oludele, Oluwaloseyi Ayomipo Olorunfemi, Olalekan John Okesanya, Jerico Bautista Ogaya, Emery Manirambona, Mohamed Mustaf Ahmed, Don Eliseo Lucero-Prisno. Innovative laboratory techniques shaping cancer diagnosis and treatment in developing countries. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-01877-w
|
| 124 |
Kohei Chida, Masanori Oshi, Arya Mariam Roy, Takafumi Yachi, Masaki Nara, Kyogo Yamada, Osamu Matsuura, Tadashi Hashizume, Itaru Endo, Kazuaki Takabe. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery 2023; 174(2) doi: 10.1016/j.surg.2023.04.030
|
| 125 |
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du. Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. Clinical and Molecular Hepatology 2024; 30(4) doi: 10.3350/cmh.2024.0058
|
| 126 |
Jintao Liang, Jianlu Liang, Xinkai Xiao, Fei Guo, Yulian Zhan, Xueqing Zhou, Zhide Zhou, Guiyin Li. A sandwich-type electrochemical sensor based on RGO-CeO2-Au nanoparticles and double aptamers for ultrasensitive detection of glypican-3. Microchimica Acta 2024; 191(11) doi: 10.1007/s00604-024-06704-7
|
| 127 |
Min Li, Biao Zhao, Zuxing Zhang, Yu Li, Yixiao Li, Yingxian Xue, Shengbo Sang, Aoqun Jian. A split-type photoelectrochemical biosensor using GSH-loaded liposomes in situ stimulation of ATA photoelectrode for the sensitive detection of AFP. Biosensors and Bioelectronics 2026; 294 doi: 10.1016/j.bios.2025.118257
|
| 128 |
Yan Lu, Bo Lin, Mengsen Li. The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1363695
|
| 129 |
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02101-z
|
| 130 |
Ana Cristina García-Gaytán, Andy Hernández-Abrego, Dalia De Ita-Pérez, Ericka de los Ríos-Arellano, Emanuel Gámez, Mauricio Díaz-Muñoz, Isabel Méndez. Metabotropic Glutamate Receptor 3 Expression During Liver Disease Progression: Association with Inflammation and Cell Viability in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2026; 27(9) doi: 10.3390/ijms27093878
|
| 131 |
Fangmin Zhong, Fangyi Yao, Xin-Lu Wang, Zihao Wang, Bo Huang, Jing Liu, Xiaozhong Wang, Lei Zhang. Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1663943
|
| 132 |
Qianle Cheng, Dengke Jia, Yawu Zhang. Prognostic Value of Preoperative Neutrophil Percentage to Albumin Ratio in Patients with Hepatocellular Carcinoma. Gastroenterology Insights 2026; 17(2) doi: 10.3390/gastroent17020029
|
| 133 |
Ziqi Wang, Yufei He, Yi Wang, Yunguo Yang, Yujun Song. Magneto-plasmonic biosensing platform mediated by localized surface plasmon bioprobes for ultrasensitive detection. Chemical Engineering Journal 2026; 545 doi: 10.1016/j.cej.2026.179888
|
| 134 |
Zesheng Wang, Weiling Lu, Zhenjun Guo, Haoran Liu, Zhiwei Yin, Shihui Ma, Zhiyu Wang, Ziyue Huang, Xiaoke Sun, Yi Xu, Judy Wai Ping Yam. Recent advances in machine learning-enhanced extracellular vesicle omics for oncology. Journal of Nanobiotechnology 2026; doi: 10.1186/s12951-026-04342-0
|
| 135 |
Lin Ning, Yuan Tian, Di Chen, Jie Han, Guanyue Xie, Jianguang Sun. Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database. Heliyon 2024; 10(18) doi: 10.1016/j.heliyon.2024.e37348
|
| 136 |
Magdalena Kędzierska, Magdalena Bańkosz. Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review. Journal of Clinical Medicine 2024; 13(23) doi: 10.3390/jcm13237131
|
| 137 |
Natchaya Polpichai, Chongkonrat Maneenil, Pojsakorn Danpanichkul, Chitchai Rattananukrom, Ashok Choudhury, Yu Jun Wong, Pimsiri Sripongpun, Suthat Liangpunsakul, Apichat Kaewdech. Current and new strategies for hepatocellular carcinoma surveillance. Gastroenterology Report 2025; 13 doi: 10.1093/gastro/goaf045
|
| 138 |
Xinying Chang, Cong Han, Haishuo Ji, Zhe Zeng, Jingyi Yang, Qirui Liu, Chao Jia, Lili Zhao, Chunlei Zhou, Shujia Chen, Wolfgang Knoll, Jia Li, Zhenglu Wang, Liyun Zhang. SPARC: A programmable molecular diagnostic platform based on a signal-triggered, self-supplied crRNA and tiered PER-transcription-CRISPR cascade for early detection of hepatocellular carcinoma. Analytica Chimica Acta 2026; 1394 doi: 10.1016/j.aca.2026.345209
|
| 139 |
Allison Poles, Nyembezi Dhliwayo, Audrey Kam. Visceral crisis in HER2-positive, AFP-producing gastric cancer. BMJ Case Reports 2026; 19(3) doi: 10.1136/bcr-2025-268475
|
| 140 |
Rohini Sharma, Aloysious D Aravinthan, Maria Qurashi, Benjamin Stenberg, Aileen Marshall, Coral Hollywood, Douglas Macdonald, Graham R Foster, Ian A Rowe, James Franklin, Janisha Patel, Katherine Caddick, Rebecca L Jones, Vanessa Hebditch, Timothy J S Cross, Monica Walsh, Stuart McPherson. Hepatocellular carcinoma surveillance: minimum standards. Frontline Gastroenterology 2025; doi: 10.1136/flgastro-2024-102907
|
| 141 |
Rency S. Varghese, Xinran Zhang, Sarada Giridharan, Muhammad Salman Sajid, Md Mamunur Rashid, Alexander Kroemer, Habtom W. Ressom. Multi-Omics Feature Selection to Identify Biomarkers for Hepatocellular Carcinoma. Metabolites 2025; 15(9) doi: 10.3390/metabo15090575
|
| 142 |
Hiroko Shimazaki, Haruki Uojima, Kazumi Yamasaki, Tomomi Obayashi, Sayaka Fuseya, Takashi Sato, Masashi Mizokami, Atsushi Kuno. M2BPgs-HCC: An Automated Multilectin Bead Array Indicating Aberrant Glycosylation Signatures Toward Hepatitis C Virus-Associated Hepatocellular Carcinoma Prognosis. Molecules 2024; 29(23) doi: 10.3390/molecules29235640
|
| 143 |
Manaswita Tappata, Jose D. Debes. Treatment and Management of Tropical Liver Disease. 2024; doi: 10.1016/B978-0-323-87031-3.00015-9
|
| 144 |
Jonathan Sun, Enric Esplugues, Alicia Bort, Magdalena P. Cardelo, Inmaculada Ruz-Maldonado, Pablo Fernández-Tussy, Clara Wong, Hehe Wang, Iwao Ojima, Martin Kaczocha, Rachel Perry, Yajaira Suárez, Carlos Fernández-Hernando. Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring. Nature Metabolism 2024; 6(4) doi: 10.1038/s42255-024-01019-6
|
| 145 |
Sireen Abdul Rahim Shilbayeh, Omnia A. Abd El‐Baset, Mohammad A. Alshabeeb, Abdalrhman Hamdan Alanizi, Naglaa F. Khedr, Rehab H. Werida. The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele‐Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization. Pharmacology Research & Perspectives 2025; 13(3) doi: 10.1002/prp2.70114
|
| 146 |
Azza Mahmoud El Sheashaey, Marium Nagah Al Zafrany Al Agha, Amr ragab Ibrahim shalaby, Salah Mohammed El Kousy, Gamalate Abd Ellatef Elgedawy. Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00376-x
|
| 147 |
Jinhui Zhou, Yao Zhang, Jing Zhang, Jingbiao Chen, Hang Jiang, Linqi Zhang, Xi Zhong, Tianhui Zhang, Lichun Chen, Yufeng Wang, Yikai Xu, Jin Wang. New strategy of LI-RADS v2018 to improve the sensitivity for small hepatocellular carcinoma ≤ 3.0 cm on extracellular-contrast enhanced MRI. European Journal of Radiology 2024; 181 doi: 10.1016/j.ejrad.2024.111830
|
| 148 |
Li He, Cui Zhang, Lan-Lan Liu, Li-Ping Huang, Wen-Jing Lu, Yuan-Yuan Zhang, De-Yong Zou, Yu-Fei Wang, Qing Zhang, Xiao-Li Yang. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World Journal of Gastrointestinal Oncology 2024; 16(6): 2463-2475 doi: 10.4251/wjgo.v16.i6.2463
Abstract(564) |
Core Tip(604) |
Full Article(HTML)(1788)
|
Full Article (PDF)-1577K(174)
|
Full Article with Cover (PDF)-1890K(301)
|
Full Article (XML)-128K(135)
|
Audio-1381K(12)
|
Peer-Review Report-217K(126)
|
Answering Reviewers-49K(126)
|
Supplementary Material-199K(133)
|
Times Cited (3)
|
Total Visits (3352)
|
Open
|
| 149 |
Subin Heo, So Yeon Kim, So Jung Lee, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin, Sang Hyun Choi, Claude B. Sirlin. LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C. American Journal of Roentgenology 2025; 224(4) doi: 10.2214/AJR.24.32433
|
| 150 |
Shajahan Azeez, Anbazhagan Sathiyaseelan, Mohana Thiruchenduran, Kaviyarasan Venkatesan, Latha Ragunathan. Chitosan–PLGA Hybrid Nanocarriers Enhance Therapeutic Delivery of Doxorubicin for Hepatocellular Carcinoma. Macromol 2026; 6(2) doi: 10.3390/macromol6020042
|
| 151 |
Dongfang Huang, Jianhuai Zhang, Jianbo Xu, Qiang Niu, Dinghua Zhou. Utility of Alpha-Fetoprotein and Ultrasound in the Diagnosis and Prognosis of Patients with Hepatocellular Liver Cancer. Journal of Multidisciplinary Healthcare 2024; doi: 10.2147/JMDH.S449276
|
| 152 |
Huan Keat Chan, Ibtisam Ismail, Faizah Ahmad, Siti Maisarah Md Ali, Norizati Razali, Nurul Husna Qaiyimah Ibrahim, Muhammad Radzi Abu Hassan. Multicenter evaluation of M2BPGi as a biomarker for liver fibrosis and hepatocellular carcinoma in chronic hepatitis B and C patients in Malaysia. Advances in Biomarker Sciences and Technology 2026; 8 doi: 10.1016/j.abst.2026.01.011
|
| 153 |
Safeer Khan, Sana Hanif, Muhammad Ali Syed, Muhammad Irfan, Ameer Fawad Zahoor, Ikram ul ah Khan, Maryam Khalid, Sundus Sonia. Diagnostic Landscape in Cancer Research. 2025; doi: 10.1016/B978-0-443-33849-6.00007-6
|
| 154 |
Ziqiang Li, Qingyong Hong, Zhizhan Ni, Zhidong Guo, Qimeng Shi, Xianqing Wang, Qi Huang, Kun Li, Bujun Ge. A Novel Nomogram for Prediction of Survival in Patients with Small Isolated Hepatocellular Carcinoma: A Population-Based and Externally Validated Study. Journal of Investigative Surgery 2025; 38(1) doi: 10.1080/08941939.2025.2536627
|
| 155 |
Yanping Xing, Xixiang Xie, Jiangtao Liu, Tao Zhao, Xiyu Liu, Pan Wu, Faquan Lin, Yong Huang. Split biosensor based on nano-enzymatic ferrocene-tyramine deposition reaction for detection of SMP30 antibody. Analytica Chimica Acta 2026; 1382 doi: 10.1016/j.aca.2025.344834
|
| 156 |
Omar Ramadan, Waleed Alahmad, Charoenkwan Kraiya. Electrochemical Biosensors for Hepatocellular Carcinoma: Advances, Analytical Performance, and Clinical Translation. Critical Reviews in Analytical Chemistry 2026; doi: 10.1080/10408347.2026.2658858
|
| 157 |
Yueyue Li, Yisheng Wang, Yingying Xiong, Xuejiao Liu, Yang Li, Ying Zhang, Haojie Lu. Comprehensive Characterization of Atypical Serum Albumin N-Glycosylation Reveals Hepatocellular Carcinoma Diagnostic Biomarkers. Analytical Chemistry 2025; 97(44) doi: 10.1021/acs.analchem.5c04997
|
| 158 |
Robeer Ghantus, Răzvan Alexandru Ciocan, Diana Schlanger, Călin Popa, Claudia Diana Gherman, Călin Vaida, Bogdan Gherman, Doina Pîslă, Nadim Al Hajjar, Andra Ciocan. Novel Biomarkers in Hepatocellular Carcinoma from Embryogenic Antigens to cfDNA. Biomedicines 2025; 13(5) doi: 10.3390/biomedicines13051020
|
| 159 |
Cailing Ye, Yaqiong Chen, Jiahao Chen, Zhongcheng Chen, Wensi Chen, Suqing Zhao, Bo Hu, Zhaoxia Li. Prognostic Value of a Novel Model for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. Journal of Clinical Laboratory Analysis 2025; 39(19) doi: 10.1002/jcla.70095
|
| 160 |
Ngo Dieu Hoa, Dao Phuong Giang, Nguyen Thi Thu Hien, Dang Thi Ngoc Dung, Mai Thanh Binh, Ngo Tat Trung, Tran Thi Thanh Huyen, Hoang Van Tong, Thirumalaisamy P. Velavan, Le Huu Song, Nghiem Xuan Hoan. Circulating miRNAs combined with AFP improve diagnostic accuracy for HBV-associated hepatocellular carcinoma. Biochemistry and Biophysics Reports 2025; 44 doi: 10.1016/j.bbrep.2025.102343
|
| 161 |
Philip Vutien, Nicole J. Kim, Mindie H. Nguyen. The Diagnosis and Staging of Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1) doi: 10.1016/j.cld.2024.08.007
|
| 162 |
Mustafa H. Ghazi, Zainab Abd Mohammed , Shahad Kh. Al-Qaisi, Osama A. Mohsein. Evaluation of Association between Tumor Markers, Hormonal Receptors, Inflammatory Biomarkers and Breast Cancer. Archives of Breast Cancer 2026; 13(1) doi: 10.32768/abc.4029185736-402
|
| 163 |
Yiyang Guo, Yanli Deng, Yuming Jia, Shiru Cao, Hong Zhang. A study on the correlation between longitudinal inflammatory biomarkers and postoperative prognosis in hepatocellular carcinoma. Biomarkers in Medicine 2026; 20(6) doi: 10.1080/17520363.2026.2671005
|
| 164 |
Jinhui Zhou, Siyu Ouyang, Haimei Chen, Dingyue Zhang, Yan Wang, Yuanqiang Xiao, Ying Zeng, Zebin Fang, Yufeng Wang, Lichun Chen, Jing Zhang, Tianhui Zhang, Xi Zhong, Qiqi Yang, XinXin Bu, Yang Yang, Jin Wang. The value of LI-RADS ancillary features and biomarker for hepatocellular carcinoma ≤ 30 mm in Western and Eastern guidelines on extracellular agent and gadoxetic acid-enhanced MRI. European Radiology 2026; 36(7) doi: 10.1007/s00330-026-12381-2
|
| 165 |
Dongkai Gao, Zumo Zhou, Lin Chen, Jun Zheng, Jinna Yang. CGREF1 facilitates the cell proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of EIF3H/ Wnt/β-Catenin signaling axis. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13808-7
|
| 166 |
Wenzhuo Xiong, Xuehui Duan, Liping Dai, Peng Wang, Hua Ye, Jianxiang Shi, Keyan Wang. Anti-OLA1 autoantibody is a potential early diagnostic marker for hepatocellular carcinoma. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1647809
|
| 167 |
Daniel Rusie, Adriana Mercan Stanciu, Letitia Toma, Elena Laura Iliescu. Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals. Cureus 2022; doi: 10.7759/cureus.24506
|
| 168 |
Weiwei Guan, Congyue Zhang, Tongguo Miao, Chen Dong, Lu Li, Xiwei Yuan, Dandan Zhao, Rong Ai, Xiaoxiao Zhang, Mengjiao Sun, Haiyan Kang, Yuemin Nan. The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S463804
|
| 169 |
Mingxing Li, Tailin Chen, Rongshi Huang, Yanhui Cen, Feilan Zhao, Rong Fan, Guozhen He. Chimeric antigen receptor-T cells targeting AFP-GPC3 mediate increased antitumor efficacy in hepatocellular carcinoma. Arab Journal of Gastroenterology 2025; 26(1) doi: 10.1016/j.ajg.2024.12.002
|
| 170 |
Piya Prajumwongs, Attapol Titapun, Vasin Thanasukarn, Apiwat Jareanrat, Natcha Khuntikeo, Krit Rattanarak, Nisana Namwat, Poramate Klanrit, Arporn Wangwiwatsin, Jarin Chindaprasirt, Supinda Koonmee, Prakasit Sa-Ngiamwibool, Nattha Muangritdech, Sawanya Charoenlappanit, Janthima Jaresitthikunchai, Sittiruk Roytrakul, Watcharin Loilome. Serum peptide biomarkers by MALDI-TOF MS coupled with machine learning for diagnosis and classification of hepato-pancreato-biliary cancers. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-14451-9
|
| 171 |
Usman Umar Liman, Asanka Sudeshini Hewage, Sumadee de Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella. Detection of serum levels of human telomerase reverse transcriptase mRNA in non-alcoholic steatohepatitis related hepatocellular carcinoma in Sri Lanka. South Asian Journal of Cancer 2026; 0 doi: 10.25259/SAJC_14_2026
|
| 172 |
Ying Li, Ke-Xing Han, Qian Su, Nan Xu, Qin-Xiu Xie, Yu-Feng Gao. Construction of a Lasso regression-based prediction model for development of cirrhosis in chronic hepatitis B. World Chinese Journal of Digestology 2023; 31(7) doi: 10.11569/wcjd.v31.i7.282
|
| 173 |
Sikander S. Gill, Rajwant K. Gill, R. C. Sobti. Handbook of Oncobiology: From Basic to Clinical Sciences. 2024; doi: 10.1007/978-981-99-6263-1_7
|
| 174 |
Muhammad Salman Sajid, Rency S. Varghese, Shafaq Saleem, Xinran Zhang, Alexander Kroemer, Habtom W. Ressom. Glycoproteome Profiling of Human Serum for Hepatocellular Carcinoma Biomarker Discovery. Journal of Proteome Research 2026; 25(7) doi: 10.1021/acs.jproteome.6c00258
|
| 175 |
Amr Elkady, Mohamed F. Hagag, Amir Elsaidy, Mohamed Elzallat, Nada Naguib, Ahmed M. El-Khawaga, Hanaa M. Elsaied. Plasmonic star-shaped gold nanoparticles for high-sensitive SERS-based detection of hepatocellular carcinoma (HCC). Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2026; 363 doi: 10.1016/j.saa.2026.128265
|
| 176 |
Yanan Ma, Cheng Lou, Jing liang, Chunyue Guo, Jinjuan Zhang, Chengjun Lu, Jiandong Zhang, Yingtang Gao. Characteristics of extracellular vesicle-derived lncRNAs during the progression of HBV-related hepatocellular carcinoma. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15237-y
|
| 177 |
Yiqing Zhu, Bang Xiao, Meng Liu, Meiting Chen, Ningqi Xia, Haiyan Guo, Jinfeng Huang, Zhiyong Liu, Fang Wang. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation. Cellular & Molecular Biology Letters 2023; 28(1) doi: 10.1186/s11658-023-00493-2
|
| 178 |
Mostafa A. Sharafeldin, Reda A. Suef, Adel A. Mousa, Dina H. Ziadah, Mohamed M.S. Farag. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV. Pathology - Research and Practice 2024; 258 doi: 10.1016/j.prp.2024.155327
|
| 179 |
Haodong Liu, Yinan Liu, Shijie Liang, Zheng Yang, Wuning Mo. Deubiquitinase-associated mRNA signature model predicts prognosis and influences the immune microenvironment in patients with hepatocellular carcinoma: An observational study. Medicine 2025; 104(30) doi: 10.1097/MD.0000000000043442
|
| 180 |
Shaqraa Musawi. Alpha-Fetoprotein as a Biomarker in Pregnancy: From Genetic Disorders to Obstetric Complications. Current Issues in Molecular Biology 2026; 48(5) doi: 10.3390/cimb48050534
|
| 181 |
Usman Umar Liman, Asanka Sudeshini Hawage, Sumadee De Silva, Saumya Madushani Samarasinghe, Kamani Hemamala Tennekoon, Rohan Chaminda Siriwardana, Madunil Anuk Niriella. Pathogenic effects of telomerase reverse transcriptase (TERT) promoter mutations in nonalcoholic steatohepatitis (NASH) related hepatocellular carcinoma (HCC) and its potentials as a diagnostic biomarker. Egyptian Journal of Medical Human Genetics 2025; 26(1) doi: 10.1186/s43042-025-00738-z
|
| 182 |
Jianping Zhang, Jing Zhao, Qingtao Wang, Rui Zhang, Yuhong Yue. Evaluating the Commutability of Reference Materials for α-Fetoprotein: Accurate Value Assignment With Multiple Systems and Trueness Verification. Annals of Laboratory Medicine 2024; 44(6) doi: 10.3343/alm.2023.0447
|
| 183 |
Olga Y. Burenina, Roman K. Makarchenko, Maria P. Rubtsova, Olga A. Dontsova. Liver‐specific lncRNAs associated with liver cancers. FEBS Open Bio 2025; 15(9) doi: 10.1002/2211-5463.70079
|
| 184 |
Xi-Ming Wang, Hui-Gang Li, Jin-Xin Xu, Xiang Wu, Hong Li. Protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma with normal alpha-fetoprotein: Current advances and controversies. World Journal of Gastrointestinal Oncology 2026; 18(5): 118297 doi: 10.4251/wjgo.v18.i5.118297
|
| 185 |
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang, Haibo Zhang. Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 2023; 4(3) doi: 10.1002/mco2.292
|
| 186 |
Stefano Mocci, Andrea Perra, Roberto Littera, Francesco Pes, Maurizio Melis, Celeste Sanna, Alessia Mascia, Michela Murgia, Caterina Mereu, Michela Lorrai, Irena Duś-Ilnicka, Giorgia Zedda, Sara Lai, Erika Giuressi, Federico Guarino, Gianfranco Serra, Michela Miglianti, Roberta Stradoni, Monica Vacca, Teresa Zolfino, Luchino Chessa, Sabrina Giglio. Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-97406-4
|
| 187 |
Alessandro Vitale, Roberta Angelico, Bruno Sensi, Quirino Lai, Emanuele Kauffmann, Irene Scalera, Matteo Serenari, Michael Ginesini, Pierluigi Romano, Alessandro Furlanetto, Francesco D’Amico. What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?. Cancers 2024; 16(5) doi: 10.3390/cancers16050966
|
| 188 |
Iván Herrera, Susana Almenara, Pablo Bellot, Cayetano Miralles, Maria Rodriguez, Lucia Gómez-González, José M. Palazón, Sonia Pascual, Pedro Zapater. Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study. Journal of Clinical and Experimental Hepatology 2024; 14(6) doi: 10.1016/j.jceh.2024.101472
|
| 189 |
Pan-Xin Ge, Yan Rong, Lu-Lu Sun, Yuqing Hu, Xianzhi Chai, Hai-Hao Han, Liangliang Zhu. A Galactose-Modified Light-Activatable Persulfurated Arene Fluorescent Probe for Targeted Imaging of Polarity and Viscosity in Liver Cancer Cells. Journal of Fluorescence 2026; 36(6) doi: 10.1007/s10895-026-04812-6
|
| 190 |
Zhao Cao, Zhijian Chen, Yun Zhang, Yahan Tan, You Shu, KunPeng Bu, Huan Zeng, Hong Shu, Junqiang Huang. Targeting metabolic dysregulation in HCC: Development and validation of a dual-biomarker diagnostic model integrating ADH1C and BHMT. Clinics and Research in Hepatology and Gastroenterology 2026; 50(5) doi: 10.1016/j.clinre.2026.102814
|
| 191 |
Alok Ghosh Chaudhuri, Saptadip Samanta, Monalisha Dey, N. S. Raviraja, Souvik Dey.
Role of Alpha-Fetoprotein in the Pathogenesis of Cancer
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(2) doi: 10.1615/JEnvironPatholToxicolOncol.2023049145
|
| 192 |
Nur Athirah Abd Rasid, Noor Azimah Muhammad. Unexplained Leg Swelling Leading to a Diagnosis of Hepatocellular Carcinoma: A Case Report. Cureus 2025; doi: 10.7759/cureus.84206
|
| 193 |
Jintao Liang, Fei Guo, Jiaying Huang, Xiaohong Tan, Lixian Sun, Zhide Zhou, Guiyin Li. An ultrasensitive label-free electrochemical aptasensing platform for Golgi protein-73 detection based on RGO-Fc-Mn3O4 nanocomposites. Microchemical Journal 2023; 193 doi: 10.1016/j.microc.2023.109138
|
| 194 |
Jintao Liang, Ruijie Yan, Chunguan Chen, Xiaoqing Yao, Fei Guo, Runqiang Wu, Zhide Zhou, Jiejing Chen, Guiyin Li. A novel fluorescent strategy for Golgi protein 73 determination based on aptamer/nitrogen-doped graphene quantum dots/molybdenum disulfide @ reduced graphene oxide nanosheets. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2023; 294 doi: 10.1016/j.saa.2023.122538
|
| 195 |
Ziheng Huang, Keyue Tian, Yiyuan Xue, Feng Luo. A promising role of noble metal NPs@MOFs in chondrosarcoma management. Nanoscale 2025; 17(6) doi: 10.1039/D4NR03878A
|
| 196 |
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction. Medicine 2023; 102(35) doi: 10.1097/MD.0000000000034937
|
| 197 |
Su-Bhin Han, Kwang Hoe Kim, Jiyoung Mun, Jong Hwan Shin, Jae-Young Kim. Dissection of Vitronectin-Regulated Secretome in Hepatocellular Carcinoma. Journal of Proteome Research 2026; 25(3) doi: 10.1021/acs.jproteome.5c01029
|
| 198 |
Landon L. Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W. Houchen. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126481
|
| 199 |
Riccardo Di Santo, Benedetta Niccolini, Enrico Rosa, Marco De Spirito, Fabrizio Pizzolante, Dario Pitocco, Linda Tartaglione, Alessandro Rizzi, Umberto Basile, Valentina Petito, Antonio Gasbarrini, Guido Gigante, Gabriele Ciasca. Artificial Intelligence for Liquid Biopsy: FTIR Spectroscopy and Autoencoder-Based Detection of Cancer Biomarkers in Extracellular Vesicles. Cells 2025; 14(23) doi: 10.3390/cells14231909
|
| 200 |
Zerun Zhang, Bin Wang, Pian Wu, Kermue Vasco Jarnda, Yuan Tian, Tianhan Kai, Cuimei Chen, Ping Ding. Advances in optical and electrochemical aptasensors for tumor biomarker alpha-fetoprotein. Microchimica Acta 2026; 193(2) doi: 10.1007/s00604-025-07758-x
|
| 201 |
Amer Latif, Riffat Saeed, Tariq Ali Banghash, Muhammad Khawar Shahzad, Hassam Ahmed, Muhammad Asif Naveed, Usama Amer. Validity of Prothrombin-induced Vitamin K antagonist versus Alpha-Fetoprotein (Tumor Markers) in Diagnosis of Hepatocellular Carcinoma, Using Computed Tomography scan as Gold Standard. Pakistan Journal of Health Sciences 2024; doi: 10.54393/pjhs.v5i07.1804
|
| 202 |
Yong-Xiang Yi, Jun-Wei Li, Xue-Hua Wan, Zhao-Di Jiang, Kan Xu, Tong Mu, Ming-Xuan Wang, Wei Guo. Reduction in the hepatocellular carcinoma antioncogene <i>SLC39A14</i> during the malignant progression of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2025; 17(10): 111454 doi: 10.4240/wjgs.v17.i10.111454
Abstract(108) |
Core Tip(109) |
Full Article(HTML)(383)
|
Full Article (PDF)-16382K(57)
|
Full Article with Cover (PDF)-16691K(70)
|
Full Article (XML)-158K(49)
|
Audio-2025K(45)
|
Peer-Review Report-240K(57)
|
Answering Reviewers-130K(66)
|
Supplementary Material-146K(35)
|
Times Cited (0)
|
Total Visits (791)
|
Open
|
| 203 |
Gedion Yilma Amdetsion, Arvind R. Murali, Chun-Wei Pan, Clive Miranda, Alexandra Sueldo, Hiwot Gebeyehu Tebeje, Daniel Guifarro, Robert Kwei-Nsoro, Vikram Kotwal. Pentraxin-3, a complementary biomarker in hepatocellular carcinoma: Systematic review and Meta-analysis. Clinica Chimica Acta 2026; 588 doi: 10.1016/j.cca.2026.121007
|
| 204 |
Gulijiamali Kahaer, Sirun Pan, Wenchen Xie, Yue Li, Chengcheng Yang, Xin Zhang, Han Wang, Yan Lu. Alpha-fetoprotein acts as a key regulator of cancer stemness in hepatocellular carcinoma via PI3K/Akt pathway. Cellular Signalling 2026; 142 doi: 10.1016/j.cellsig.2026.112401
|
| 205 |
Suman Supratik, Ram Mohan Jha, Manaswi Acharya, Roshna Adhikari, Arun Gautam, Soniya Dulal. Case study of elevated alpha-fetoprotein secondary to drug-induced hepatitis mimicking germ cell tumor: a diagnostic pitfall. Annals of Medicine & Surgery 2026; doi: 10.1097/MS9.0000000000005305
|
| 206 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S341195
|
| 207 |
Ashwin Rammohan, Dinesh Jothimani, Kunkumabalasubramanian Sreedurgalakshmi, Mohammed Farouk, Srinivasan Lakshmi, G. Vasanthakumar, Simon Evangeline, Komalavalli Subbiah, Mukul Vij, Jeyanthi Rebecca, Srikar Raman, Mohamed Rela. Validation of a Multiplex Hypermethylation-based Blood Test to Detect Hepatocellular Carcinoma: A Prospective Case-control Study. Journal of Clinical and Experimental Hepatology 2025; 15(5) doi: 10.1016/j.jceh.2025.102578
|
| 208 |
Peng Zhang, Chenqi Zhang, Min Jia, Yongdong Pan, Shuo Wu, Jianxin Cheng, Lujie Song, Zizhen Ming. An automated and portable magnetically-controlled microfluidic chip platform with dual detection modes for sensitive AFP quantification. Analytica Chimica Acta 2026; 1408 doi: 10.1016/j.aca.2026.345570
|
| 209 |
Giuseppe A. Colloca, Antonella Venturino. Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis. Cancer 2024; 130(10) doi: 10.1002/cncr.35199
|
| 210 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22) doi: 10.3390/jcm13226770
|
| 211 |
Adithya Jayaprakash Kamath, Siva S., Abir Chakraborty, Saraswathy R., Aswathy R. Devan, Gowri Rajesh, Nikhil K. Haridas, Pavithran K., Gautam Sethi, Lekshmi. R. Nath. Molecular Precision Medicine in Cancer. Cancer Drug Discovery and Development 2026; doi: 10.1007/978-3-032-24071-2_3
|
| 212 |
David Cheishvili, Chifat Wong, Mohammad Mahbubul Karim, Mohammad Golam Kibria, Nusrat Jahan, Pappu Chandra Das, Md. Abul Khair Yousuf, Md. Atikul Islam, Dulal Chandra Das, Sheikh Mohammad Noor-E-Alam, Moshe Szyf, Sarwar Alam, Wasif A. Khan, Mamun Al Mahtab. A high-throughput test enables specific detection of hepatocellular carcinoma. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-39055-7
|
| 213 |
Rehab I. Moustafa, Sally Farouk, Noha G. Bader El Din, Hend I. Shousha, Ahmed Khairy, Yasser K. Elesnawy, Heba Shawky, Ahmed M. Gabr, Ashraf O. Abdelaziz, Amr Abdelaal, Hassan Elsayed. Assessment of peripheral gene expression signatures as predictive biomarkers for hepatocellular carcinoma following DAA treatment. Journal of Genetic Engineering and Biotechnology 2025; 23(4) doi: 10.1016/j.jgeb.2025.100583
|
| 214 |
Feihang Wang, Xiaolong Zhang, Yadan Xu, Qingyue Xu, Kai Yuan, Yi Dong, Wenping Wang. Diagnostic value of contrast-enhanced ultrasound in serum biomarker negative hepatocellular carcinoma and colorectal cancer liver metastasis. Clinical Hemorheology and Microcirculation 2025; 90(4) doi: 10.1177/13860291251358021
|
| 215 |
Zahraa Qusairy, Miran Rada. Glycosylation in cancer: mechanisms, diagnostic markers, and therapeutic applications. Molecular and Cellular Biochemistry 2025; 480(9) doi: 10.1007/s11010-025-05303-1
|
| 216 |
Mohamed Abdelaleim Abdelaziz, Abdallah Mohammed Elagali, Ayman S. Soliman, Hader I. Sakr, Ahmed A. Ibrahim, Alaa H. Huzien, Jakleen Z. Abujamai, Ahmed A. Damanhory, Safy S. Gaber. Assessment circulating micro-RNA-192 in Egyptian patients with non-viral liver cirrhosis and hepatocellular carcinoma. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-025-04304-2
|
| 217 |
Kyeezu Kim, Yinan Zheng, Brian T. Joyce, Drew R. Nannini, Jun Wang, Yishu Qu, Claudia A. Hawkins, Edith Okeke, Olufunmilayo A. Lesi, Lewis R. Roberts, Demirkan B. Gursel, Fatimah B. Abdulkareem, Alani S. Akanmu, Mary J. Duguru, Pantong Davwar, David Paul Nyam, Rahmat A. Adisa, Godwin Imade, Jian-Jun Wei, Masha Kocherginsky, Kwang-Youn Kim, Wasiu L. Adeyemo, Emuobor Odeghe, Firas H. Wehbe, Chad Achenbach, Atiene Sagay, Folasade Ogunsola, Robert L. Murphy, Lifang Hou. Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatology International 2025; 19(3) doi: 10.1007/s12072-024-10768-1
|
| 218 |
Thuy Thi Thu Pham, Dat Tan Ho, Toan Bao Nguyen, Hai Thanh Phan. Clinical performance of GAAD score, alpha-fetoprotein, and PIVKA-II in diagnosing hepatocellular carcinoma in the Vietnamese cohort. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03651-4
|
| 219 |
Shan Wang, Zhen-Peng Chang, Yue Yin, Yi-Ning Li, Kang Cheng, Yu-Shang Zhao, Lin-Lin Cao. The Combination of Machine Learning and Metabolomics for the Clinical Diagnosis of Hepatocellular Carcinoma. Journal of Proteome Research 2026; 25(6) doi: 10.1021/acs.jproteome.5c00684
|
| 220 |
Lixing Chen, Siyuan Cheng, Dongling Zhu, Guangfa Bao, Ziqiang Wang, Xiaoyun Deng, Xiaoguang Liu, Xiang Ma, Jun Zhao, Lei Zhu, Xiaohua Zhu. Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging. Molecular Pharmaceutics 2025; 22(1) doi: 10.1021/acs.molpharmaceut.4c00838
|
| 221 |
Ioannis D. Kostakis, Nikolaos Kotelis, Danial Safavi, Satheesh Iype. Preoperative blood tests provide diagnostic and prognostic information about patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2025; 37(2) doi: 10.1097/MEG.0000000000002896
|
| 222 |
Ioana Manea, Speranta Maria Iacob, Razvan Iacob, Alina-Veronica Ghionescu, Andrei Sorop, Roxana Elena Saizu, Daria-Ana-Arina Gheorghe, Delia Prisecariu, Simona Olimpia Dima, Liliana Simona Gheorghe. Exploring the Predictive Value of Circulating Cell-Free DNA Within a Multiparameter Panel for Hepatocellular Carcinoma Detection. Life 2026; 16(7) doi: 10.3390/life16071079
|
| 223 |
Pritam Bhagwan Bhosale, Abuyaseer Abusaliya, Hun Hwan Kim, Vetrivel Preethi, Se Hyo Jeong, Min Yeong Park, Chung Kil Won, Jeong Doo Heo, Meejung Ahn, Je Kyung Seong, Gon Sup Kim. Comprehensive analysis of Apigetrin's effects on liver cancer cells: Insights from bioinformatics, in vitro studies, and next-generation transcriptome sequencing. Molecular and Cellular Probes 2025; 79 doi: 10.1016/j.mcp.2025.102012
|
| 224 |
Chang-Yi Lu, Kun-Feng Tsai, Chia-Jui Yen, Chueh-Jung Hsieh, Pey-Jey Peng, Shao-Chang Huang, Meng-Rong Chuang, Chi-Jen Chu. Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01599-x
|
| 225 |
Yifeng Yang, Yan Wei, Yilian Zhao, Chao Ye, Dan Zeng, Xiaoxing Zhou, Mengru Xie, Xingcai Chen, Jilin Qing, Zhizhong Chen. Up-regulation of blood-circulating TIM-4-expressing monocytes and potential diagnostic biomarker sTIM-4 in primary liver cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-14361-w
|
| 226 |
Cai Gao, Xuebing Li, Xinwei Liu, Sha Yan, Xiaodan Ran, Jingxian Han. Identification of novel circulating protein biomarkers for hepatocellular carcinoma superior to alpha-fetoprotein through a stemness index and secretome analysis. World Journal of Surgical Oncology 2026; 24(1) doi: 10.1186/s12957-025-04189-z
|
| 227 |
Ke Huang, Myoung Ok Kim. Hepatocellular Carcinoma Over Three Decades: from Screening Evolution to Integrated Therapeutic Strategies. Journal of Cancer Prevention 2026; 31(2) doi: 10.15430/JCP.25.054
|
| 228 |
Yu Zeng, Wenlin Feng, Xiaozhan Yang, Xin Zou. Microfluidic photoelectrochemical immunosensor based on BiOCl@au/CdS heterojunction for the trace detection of liver cancer marker. Bioelectrochemistry 2025; 166 doi: 10.1016/j.bioelechem.2025.109047
|
| 229 |
Khaled Mahmoud Mohiedeen, Mona Moustafa Tahoon, Christina Samir Sadek Hanna, Mohamed Adel Abdel Aziz. Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-023-00307-2
|
| 230 |
Yu-Ping Chang, Yun-Chu Chen, Chen-Hua Liu. Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies. Cancers 2026; 18(1) doi: 10.3390/cancers18010158
|
| 231 |
Jamie Klein, Ana Catalina Arce-Clachar, Kristin Bramlage, Stavra Xanthakos, Rachel Sheridan, Marialena Mouzaki. Elevated Alpha-Fetoprotein Levels in Children with Metabolic Dysfunction-Associated Liver Disease. Childhood Obesity 2025; 21(6) doi: 10.1089/chi.2025.0010
|
| 232 |
Namrata Anand, Sulin Wu, Zhoubo Guo, Marcos Santiago Figueroa, Lauren Jung, Mingyang Li, Irun Bhan, Joseph W. Franses. Novel Blood-Based Liquid Biopsy Approaches in Hepatocellular Carcinoma. JCO Oncology Advances 2025; (2) doi: 10.1200/OA-25-00132
|
| 233 |
Emmanuel Kwaku Ofori, Dziedzorm Wormenor. Biomarker Landscape in Cancer Research. 2025; doi: 10.1016/B978-0-443-33902-8.00017-1
|
| 234 |
Ga Young Moon, Hyun Sung Park, Ha Neul Kim, Hei-Gwon Choi, Yonghan Han, Hyuk Soo Eun, Tae Hee Lee, Jiyoon Bu. Cell-Free DNA Versus Circulating Tumor Cells: A Pilot Study of Alpha-Fetoprotein Analysis for Diagnosis and Treatment Monitoring in Hepatocellular Carcinoma. Biosensors 2025; 15(9) doi: 10.3390/bios15090579
|
| 235 |
Dimo Stoyanov, George S. Stoyanov, Martin N. Ivanov, Radoslav H. Spasov, Anton B. Tonchev. Transcription Factor Zbtb20 as a Regulator of Malignancy and Its Practical Applications. International Journal of Molecular Sciences 2023; 24(18) doi: 10.3390/ijms241813763
|
| 236 |
Shunwang Cao, Fei Zhong, Xueying Chen, Sikai Ke, Xiangrong Zhong, Tingting Li, Yanhua Sha, Chunmin Kang, Sheng Qin, Hongmei Wang, Yi Wang, Shuzhi Liao, Peifeng Ke. The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma. Molecular Medicine Reports 2024; 31(2) doi: 10.3892/mmr.2024.13409
|
| 237 |
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S352057
|
| 238 |
Liuyi Lu, Chunling Zhu, Liling Yi, Siting Li, Mengli Fan, Jiayao Lin, Qiliu Peng. The diagnostic value of midkine as a novel serum biomarker in alpha-fetoprotein-negative hepatocellular carcinoma. The International Journal of Biological Markers 2025; 40(3) doi: 10.1177/03936155251358265
|
| 239 |
Jieyan Liu, Shihua Luo, Siting Chen, Guanfeng Chen, Yiping Zhu, Yuxin Lou, Rui Fan, Ye Zhang, Jiezhen Pan, Chenyang Zhu, Liyun Xu, Ling Li. Dual-function CRISPR/Cas12a assisted strand displacement reaction with RuHex-loaded DNA condensates for ultrasensitive electrochemical detection of hepatocellular carcinoma mRNA. Biosensors and Bioelectronics 2026; 304 doi: 10.1016/j.bios.2026.118610
|
| 240 |
Xin Li, Yi-Fei Liu, Chen-Yao Zhou, Jun Lu, Guo-Wei Wang, Zi-Jie Tang, Zi-Chao Tu, Yong-Yi Zeng, Wei Guo, Ji-Li Li, Jia-Hao Xu, Chao Li, Ming-Da Wang, Feng Shen, Fei Wu, Tian Yang. Development and validation of the APTNM staging system: Integration of serum biomarkers with TNM classification for enhanced prognostic stratification following hepatectomy for hepatocellular carcinoma. European Journal of Surgical Oncology 2026; 52(2) doi: 10.1016/j.ejso.2026.111384
|
| 241 |
Dinesh Jothimani, Sathish Srinivasan, Evangeline Simon, Lexmi Priya Raju, Hemalatha Ramachandran, Abraham Sam Rajan, Komalavalli Subbiah, Mukul Vij, Mohamed Rela. Hepatocellular carcinoma: PIVKA-II may be unsuitable for Indian patients. Laboratory Medicine 2026; 57(1) doi: 10.1093/labmed/lmaf065
|
| 242 |
Zhe Cao, Ming Xie, Xu Ye, Bin Wu, Huiqing Wang, Guodong Chen, Deliang Cao, Boqing Wang, Xi Zeng, Zhiliang Sun. Diagnostic Performance of Serum AKR1B10 in Early‐Stage and AFP‐Negative Hepatocellular Carcinoma: A Multicentre Study. Liver International 2026; 46(8) doi: 10.1111/liv.70732
|
| 243 |
Ling Luo, Xiaochen Wang, Xujian Peng, Runqiang Zhong, Xuejing Xuan, Haixiong Lin, Xianghua Lin, Chaohui Duan. Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers. PeerJ 2025; 13 doi: 10.7717/peerj.19712
|
| 244 |
Xiaoyun Bin, Yu Luo, Zefeng Sun, Chaoqun Lin, Peng Huang, Zhenbo Tu, Ling Li, Cong Qu, Jiamin Long, Sufang Zhou. The Role of H2-Calponin Antigen in Cancer Metastasis: Presence of Autoantibodies in Liver Cancer Patients. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms24129864
|
| 245 |
Ze-Long Jin, Li-Jun Zhao. Construction of a nomogram for predicting the risk of primary liver cancer occurrence in patients with liver cysts using CT imaging features combined with alpha-fetoprotein. Medicine 2025; 104(22) doi: 10.1097/MD.0000000000042719
|
| 246 |
Luyao Liu, Lei Liu, Yan Wang, Zheng Fang, Yangyang Bian, Wenyao Zhang, Zhongyu Wang, Xianchun Gao, Changrui Zhao, Miaomiao Tian, Xiaoyan Liu, Hongqiang Qin, Zhimou Guo, Xinmiao Liang, Mingming Dong, Yongzhan Nie, Mingliang Ye. Robust Glycoproteomics Platform Reveals a Tetra‐Antennary Site‐Specific Glycan Capping with Sialyl‐Lewis Antigen for Early Detection of Gastric Cancer. Advanced Science 2024; 11(9) doi: 10.1002/advs.202306955
|
| 247 |
苏淮 于. The Diagnostic Value of Serum G-Test in Hepatocellular Carcinoma. Medical Diagnosis 2023; 13(03) doi: 10.12677/MD.2023.133057
|
| 248 |
Antonella Farina, Gaia Cicolani, Valentina Viggiani, Matteo Maini, Antonio Angeloni, Emanuela Anastasi. Differential Associations of PIVKA-II with Epithelial and Mesenchymal Features in HCC and PDAC. International Journal of Molecular Sciences 2025; 26(15) doi: 10.3390/ijms26157581
|
| 249 |
Yifeng Xie, Zixuan Wang, Zhiwen Zeng, Tongyao Xin, Shaofei Yuan, Feiwei Qin, Zhonglin Chen. Applications of Artificial Intelligence in Cancer Diagnosis and Treatment. Cancer Medicine 2026; 15(8) doi: 10.1002/cam4.72143
|
| 250 |
S. Greeshma Sai, P. Nirmala. Effective methods for detecting liver cancer with higher accuracy using CNN and comparing it to logistic regression. INTERNATIONAL CONFERENCE ON NEWER ENGINEERING CONCEPTS AND TECHNOLOGY: ICONNECT-2024 2025; 3270 doi: 10.1063/5.0263143
|
| 251 |
Muhammad Salman Sajid, Rency S. Varghese, Alexander Kroemer, Habtom W. Ressom. Low-Abundance Serum Protein Biomarker Candidates for HCC in Patients with Liver Cirrhosis. Journal of Proteome Research 2025; 24(7) doi: 10.1021/acs.jproteome.5c00231
|
| 252 |
Yuying Cai, Lingna Lyu, Jiayi Ma, Xiaoru Wang, Wenxia Ma, Jiming Yin, Shanshan Wang. Integrated serum proteomics and metabolomics reveal an INR-associated multi-omics signature in hepatocellular carcinoma. Clinical Proteomics 2026; 23(1) doi: 10.1186/s12014-026-09603-6
|
| 253 |
Habiba M. Ismail, Abdelrahman A. Attia, Amr Abdelaal, Rana A. Youness. MIAT, HEIH, and HOTAIR: A novel LncRNA signature in non-metastatic hepatocellular carcinoma patients. Current Molecular Pharmacology 2025; 18(1) doi: 10.1016/j.cmp.2025.11.002
|
| 254 |
Akiko Eguchi, Motoh Iwasa, Yasuyuki Tamai, Minori Yamada, Koji Okuno, Ryuta Shigefuku, Kyoko Yoshikawa, Mina Tempaku, Koji Sakaguchi, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, Tetsuji Yamaguchi, Hayato Nakagawa. The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.993705
|
| 255 |
Elizabeth Zheng, Francis Yao. Real-World Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1) doi: 10.1016/j.cld.2024.08.002
|
| 256 |
Shih-Chung Huang, Chao-Cheng Huang, Chou-Yuan Ko, Cheng-Yi Huang, Ching-Han Liu, Yung-Kuo Lee, Tung-Yuan Chen, Chao-Wen Hsueh, Shiow-Jyu Tzou, Ming-Hong Tai, Tsung-Hui Hu, Ming-Chao Tsai, Wen-Chin Lee, Yu-Cheng Ho, Cheng-Chun Wu, Yi-Chen Chang, Jung-Jui Chang, Kai-Hsi Liu, Chiao-Ching Li, Zhi-Hong Wen, Chen-Lin Chang, Tian-Huei Chu. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma. Gene 2023; 865 doi: 10.1016/j.gene.2023.147331
|
| 257 |
Cong Li, Yibo Sun, Jing Din, Pengfei Cheng, Feng Wu, Yuanming Qiang, Guangming Li. Predictive Value of Preoperative Serum Substance P Levels for Post-Transplant Recurrence in Patients With Hepatocellular Carcinoma. Transplantation Proceedings 2025; 57(10) doi: 10.1016/j.transproceed.2025.10.010
|
| 258 |
Chung-Che Tsai, Chun-Yu Wang, Hsu-Hung Chang, Phebe Ting Syuan Chang, Chuan-Hsin Chang, Tin Yi Chu, Po-Chih Hsu, Chan-Yen Kuo. Diagnostics and Therapy for Malignant Tumors. Biomedicines 2024; 12(12) doi: 10.3390/biomedicines12122659
|
| 259 |
Yuli Zhou, Siren Feng, Yi Chen, Bo Lin, Wei Li, Xu Dong, Kun Liu, Qiushi Yin, Mengsen Li, Mingyue Zhu. AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K/AKT Signalling Pathway. Journal of Cellular and Molecular Medicine 2026; 30(11) doi: 10.1111/jcmm.71226
|
| 260 |
Yi‐Fan Zhang, Shaoli Lin, Zhen Xiao, Mitchell Ho. A proteomic atlas of glypican‐3 interacting partners: Identification of alpha‐fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer. Proteoglycan Research 2024; 2(4) doi: 10.1002/pgr2.70004
|
| 261 |
Jiawei Lin, Jie Li, Yifan Kong, Junhui Yang, Yunjie Zhang, Guoqing Zhu, Zhijie Yu, Jinglin Xia. Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12049-4
|
| 262 |
Soyul Ahn, Seung Eun Baek, Yeuni Yu, Eun Sun Kim, Kyungjae Myung, Yun Hak Kim, Chang-Kyu Oh. The role of AP2M1 in oncofetal characteristics: integrative in silico, in vitro, and in vivo analyses using zebrafish models. European Journal of Medical Research 2025; 31(1) doi: 10.1186/s40001-025-03583-3
|
| 263 |
Yuya Miura, Ryo Ashida, Yukiyasu Okamura, Katsuhisa Ohgi, Yoshiyasu Kato, Shimpei Otsuka, Hideyuki Dei, Rui Sato, Katsuhiko Uesaka, Teiichi Sugiura. Significance of Evaluating Tumor Markers in the Oncological Criteria for Resectability in Hepatocellular Carcinoma. Hepatology Research 2026; 56(4) doi: 10.1111/hepr.70096
|
| 264 |
Hengzhou Zhu, Haoyan Chen, Xiaodan Zhu, Baonan Zhang, Chunhui Jin. Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1462512
|
| 265 |
Josephine Yu Yan Yap, Laura Shih Hui Goh, Ashley Jun Wei Lim, Samuel S. Chong, Lee Jin Lim, Caroline G. Lee. Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma. Cancers 2023; 15(14) doi: 10.3390/cancers15143749
|
| 266 |
Yun Cheng, Yan-Sha Sun, Yong-Ming He. ST2, PIVKA-II, CEA, CA125 and their combinations in elderly liver metastases cancers: Development of a diagnostic scoring model. World Journal of Gastrointestinal Oncology 2026; 18(7): 118940 doi: 10.4251/wjgo.v18.i7.118940
|
| 267 |
Nadia M. Hamdy, Al-Aliaa M. Sallam, Ola Elazazy, Ahmed M. Kabel, Rania M. Salama, Shaimaa A. Gouhar, Sherien M. El-Daly, Samar F. Darwish. LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04285-7
|
| 268 |
Chuanbao Cui, Ming Xu, Qinglong Guan, Xuejian Wang, Guangcheng Yang, Zhen Zhang, Jingjing Du. Electrochemical detection of alpha-fetoprotein using graphene-assisted sensors: A novel approach for liver cancer screening. Alexandria Engineering Journal 2025; 123 doi: 10.1016/j.aej.2025.03.052
|
| 269 |
Jinhong Du, Shu Han, Rui Song, Jianze Wang, Linyu Zhang, Yueyang Xu, Haoyi Zhou, Feng Wang, Sen Qin, Da Xu, Yameng Hao, Kui Li, Xin Zhou, Jiadong Wang, Luyang Sun, Zhi Yang, Zhaofei Liu. Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer. Nature Nanotechnology 2026; 21(7) doi: 10.1038/s41565-026-02196-z
|
| 270 |
Yiwen Zheng, Liquan Zhu, Kang Yao, Danhao Tao, Chaoshen Wu, Yibing Zhou, Da Qian, Jinbing Sun, Chaoqi He. Dual-mode fluorescence and UV-vis aptasensor for hepatocellular carcinoma detection using magnetic separation. Microchimica Acta 2026; 193(8) doi: 10.1007/s00604-026-08287-x
|
| 271 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8) doi: 10.3390/jpm14080798
|
| 272 |
Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng, Takaya Shimura. Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers. Canadian Journal of Gastroenterology and Hepatology 2026; 2026(1) doi: 10.1155/cjgh/1491679
|
| 273 |
Zhiyong Du, Shengju Yin, Bing Liu, Wenxin Zhang, Jiaxu Sun, Meng Fang, Yisheng Xu, Kun Hua, Pengfei Tu, Guoliang Zhang, Ying Ma, Yingyuan Lu. Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma. Heliyon 2023; 9(5) doi: 10.1016/j.heliyon.2023.e16083
|
| 274 |
Maged Tharwat Elghannam, Moataz Hassan Hassanien, Yosry Abdelrahman Ameen, Gamal Mohammed ELattar, Ahmed Aly ELRay, Mohammed Darwish ELTalkawy. Remarkable alpha-fetoprotein elevation and pseudo-infarction of cirrhotic liver: case report. Exploration of Digestive Diseases 2024; doi: 10.37349/edd.2024.00041
|
| 275 |
Lihong Shen, Lijia Shao, Shengchun Feng. Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma. Journal of Laboratory Medicine 2025; 49(1) doi: 10.1515/labmed-2024-0035
|
| 276 |
Martyna Drupka, Krzysztof Pol, Lukasz Holubiuk, Weronika Walecik-Kot. An Unexpected Cause of Extreme Hyperbilirubinemia and Acute Renal Failure: A Case of Weil’s Disease in Poland. Cureus 2026; doi: 10.7759/cureus.108855
|
| 277 |
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano. Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites 2024; 14(9) doi: 10.3390/metabo14090513
|
| 278 |
Xingxing Wang, Zhen Huang, Lili Huang, Yi Wang, Congxiang Huang, Xiaoying Zhang, Xiantu Zhang. Expressional and prognostic value of cytokine receptor-like factor 3 in liver hepatocellular carcinoma patients via integrated bioinformatics analyses and experiments. Sage Open Medicine 2026; 14 doi: 10.1177/20503121261440458
|
| 279 |
Jin‐Seong Hwang, Sugi Lee, Gyeonghwa Kim, Hoibin Jeong, Kiyoon Kwon, Eunsun Jung, Yuna Roh, Taesang Son, Hana Lee, Moo‐Seung Lee, Kyoung‐Jin Oh, Hye Won Lee, Yu Rim Lee, Soo Young Park, Won Young Tak, Hyun Seung Ban, Hyun‐Soo Cho, Mi‐Young Son, Jang‐Seong Kim, Keun Hur, Dae‐Soo Kim, Tae‐Su Han. A serum exosomal microRNA‐based artificial intelligence diagnostic model for highly accurate detection of hepatocellular carcinoma. Cancer Communications 2025; 45(9) doi: 10.1002/cac2.70043
|
| 280 |
Reza Elahi, Yassine Alami Idrissi, Anwaar Saeed. CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation. Cancer Treatment Reviews 2025; 141 doi: 10.1016/j.ctrv.2025.103046
|
| 281 |
Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun. Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area. Cancers 2023; 16(1) doi: 10.3390/cancers16010150
|
| 282 |
Wen Yang, Ling Liu, Jianliang Li, Yingchao Liu, Lin Rong, Junjie Ma, Rongchen Li, Qiuyue Zhang, Yugang Liu. Abnormal expression of miR-668-3p in non-small cell lung cancer patients and its correlation with serum-related tumor markers. Journal of Cardiothoracic Surgery 2025; 20(1) doi: 10.1186/s13019-024-03220-w
|
| 283 |
Shusheng Liu, Hongtao Li, Rongning Liang. Recent advances in polymeric membrane-based potentiometric ion-selective sensors for disease diagnosis. Ionics 2026; 32(3) doi: 10.1007/s11581-026-06983-5
|
| 284 |
Xiaoyuan Hu, Fa Huang, Jiyou Yao, Jiaxian Lv, Jialuo Mai, Ning Li, Minqiang Lu. Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05787-3
|
| 285 |
Kunqiang Deng, Kunfeng Chen, Sai Huang, Jinkai Li, Zongming Liu. Research Progress of Persistent Luminescence Nanoparticles in Biological Detection Imaging and Medical Treatment. Materials 2025; 18(17) doi: 10.3390/ma18173937
|
| 286 |
Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary. Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. Cancers 2024; 16(23) doi: 10.3390/cancers16233933
|
| 287 |
Elena I. Dyachenko, Lyudmila V. Bel’skaya. The Mechanism and Pathways of Formation and Modification of Salivary Metabolic Profile in Cancer. Current Issues in Molecular Biology 2026; 48(7) doi: 10.3390/cimb48070728
|
| 288 |
Panchali Saha, Pooja Malu, Poonam Joshi, Arti Hole, Pankaj Chaturvedi, Sonal Vahanwala, C. Murali Krishna. Raman Spectroscopy of Biofluids: Fusion Strategies for Detecting Oral Potentially Malignant Disorders and Oral Cancers. Applied Spectroscopy 2026; doi: 10.1177/00037028261445469
|
| 289 |
Xiaona Fu, Yusheng Guo, Yanjie Yang, Shanshan Jiang, Bingxin Gong, Jie Lou, Lianwei Miao, Yixing Li, Peng Sun, Sichen Wang, Lixia Wang, Lian Yang. Mediation and prognostic value of apparent diffusion coefficient in HCC patients receiving immune checkpoint inhibitors. Insights into Imaging 2025; 16(1) doi: 10.1186/s13244-025-02115-1
|
| 290 |
Dongna Xie, Shengnan Jia, Nian Wang, Lianghai Hu. . Advances in Clinical Chemistry 2026; 132 doi: 10.1016/bs.acc.2026.01.001
|
| 291 |
Diana Gabriela Domínguez-Lazcano. Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology 2024; 17(11) doi: 10.62347/QSII4050
|
| 292 |
Ji Shi, Xu Zhu, Jun-Bo Yang. Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer. World Journal of Hepatology 2025; 17(1): 102273 doi: 10.4254/wjh.v17.i1.102273
|
| 293 |
Asahiro Morishita, Kyoko Oura, Hiroki Tai, Rie Yano, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Miwa Tatsuta, Takashi Himoto, Hideki Kobara. Advances in the Therapeutic Landscape of Hepatocellular Carcinoma: Current Strategies and Future Perspectives. Cancers 2026; 18(4) doi: 10.3390/cancers18040609
|
| 294 |
Jinhai Wang, Li Ma, Jinjuan Wang, Zhe Ma, Weiwei Wang, Songning Yu. Circadian rhythm-based prognostic features predict immune infiltration and tumor microenvironment in molecular subtypes of hepatocellular carcinoma. Open Life Sciences 2025; 20(1) doi: 10.1515/biol-2025-1208
|
| 295 |
Zhongjing Kang, Kai Jin, Junpeng Jing, Tian jiao Wang. The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer. Disease Markers 2022; 2022 doi: 10.1155/2022/8640999
|
| 296 |
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Current Issues in Molecular Biology 2024; 46(6) doi: 10.3390/cimb46060356
|
| 297 |
Navneet Kaur, Mary Jean Savitsky, Michael Lipscomb, Dazhi Yang, Jamel Ali. A Microfibrous Extracellular Matrix Platform for In Vitro Hepatotoxicity Screening: A Next-Generation Model for Humanized Liver Research. ACS Pharmacology & Translational Science 2026; 9(1) doi: 10.1021/acsptsci.5c00567
|
| 298 |
Saira Rafaqat, Iqra Noshair, Momina Shahid, Sadaf Bibi, Ramsha Hafeez, Hafsa Hamid. Correlation between prognostic markers and clinical parameters in hepatocellular carcinoma: Pathophysiological aspects to therapeutic targets. World Journal of Gastrointestinal Oncology 2025; 17(5): 106278 doi: 10.4251/wjgo.v17.i5.106278
|
| 299 |
Su-Liang Chen, Yong Seng Low, Bo-Ru Huang, Che-Hao Lu, Wei-Chun Lan, Ren-Huang Wu, Hsing-Ying Lin, Andrew Yueh, En-Chi Hsu. Blu-Ray-Based Quantification of CD98+ Extracellular Vesicles for Early Detection of Hepatocellular Carcinoma. Cancers 2026; 18(7) doi: 10.3390/cancers18071086
|
| 300 |
JianKun Liang, XiaoWen Xin, Ai Chen, Wei Li, ZhenLong Sun, Nan Wang, Peng Liu, MingYi Wang. Overview of combined adjuvant strategies for tumor biomarker detection. Tumori Journal 2026; doi: 10.1177/03008916261425908
|